Biotechnology Forums

Basic Information:
Brigham Young University seeks to develop students of faith, intellect and character who have the skills and the desire to continue learning and to serve others throughout their lives. Established in 1875, the university provides an outstanding education in an atmosphere consistent with the ideals and principles of its sponsor, The Church of Jesus Christ of Latter-day Saints.

Undergraduate Programs:
The Biology major major provides students with current understanding of the full breadth of biology. The course of study is comprehensive and integrates knowledge across molecular, cellular, organismal, and ecological levels of organization. Students that earn this degree come to understand the biological world in its broadest sense. This degree focuses on understanding the diversity of life, emphasizing whole organism biology in ecological and evolutionary contexts.

The Bioinformatics undergraduate major at Brigham Young University is an interdisciplinary program offering substantial training in both the biological sciences and the physical and mathematical sciences; our program emphasizes the integration of computer science with genetics and molecular biology. A foundation in mathematics and statistics provides the basis for acquiring computer programming, data basing, and operating system skills. Students attracted to this program have dual interests in computer science and biology and find it an excellent choice for their broad interests. Students who complete this program either enter the top graduate programs in bioinformatics and computational biology in the world, enter leading professional schools (including law school, medical school, or dental school), or find employment in biotechnology, pharmaceutical, or software development companies.

A major in microbiology offers preparation for continued education or for immediate employment. Microbiology is the preferred degree for students who desire an advanced degree (MS or PhD) in microbiology, virology, immunology, parasitology or cell biology. It is also a helpful degree for students who are planning to attend medical or dental school, because of the breadth of the exposure of medical relevance. Graduates are qualified to enter the workforce with government agencies, institutes, or industry (biotech, cosmetic, food and water protection, health care, hospital, or pharmaceutical, etc.).

The Molecular Biology major includes core classes in chemistry, biology, and molecular biology as well as classes in physics and math. Lab research experience is an especially beneficial element of the program. This experience can also open opportunities to present papers and contribute to publications. Elective courses include topics in plant genetics and breeding, biochemistry, nutritional science, microbiology and human biology.

The College of Life Sciences at Brigham Young University offers an undergraduate degree in Neuroscience. The Neuroscience programs at Brigham Young University provide excellent interdisciplinary training in the classroom as well as experience in laboratory research settings for both graduate and undergraduate students. The Neuroscience Center at BYU was established in the Summer of 1999. While it was once necessary for students to apply to become a neuroscience major, that is no longer the case. Now, students interested in studying neuroscience simply need to go to the Life Sciences Advisement Center to meet with an adviser and declare a neuroscience major.

Undergraduate tuition: $2425/semester for members of the Church of Latter-Day Saints; $4850/semester for non-members. Financial assistance is available in the form of scholarships, grants, and loans. Students should complete the FAFSA to be eligible for financial aid.

Graduate Programs:
The primary goal of the doctoral program in the Biology Department is to provide advanced training in ecology and evolutionary biology, and experience in biology teaching. The program features an exciting range of subdisciplines, including evolutionary ecology, bioinformatics, systematics and phylogenetics, population, community, and ecosystem biology, and conservation. original research and teaching are emphasized to prepare students for careers in academics, and leadership positions in government or industrial settings. Faculty members do research in a variety of freshwater, marine, and terrestrial environments on several continents across a broad spectrum of taxa (vascular plants, nematodes, crustaceans, insects, fishes, amphibians, reptiles, and mammals). Doctoral research frequently combines field work with computational and laboratory work. The program is enhanced by excellent on-campus resources including: a natural history museum with extensive collections, state-of-the-art gene sequencing facilities, a controlled-environment laboratory facility, electron microscopy, herbarium, and greenhouse. The program provides a scholarly setting designed to fit the individual goals of students.

Rapid advances in molecular research techniques and new ways of thinking about biological networks and interactions have made this an exciting time to work in the biomedical sciences. The Department of Microbiology and Molecular Biology (MMBIO) represents the best BYU has to offer in the way of advanced classroom instruction and cutting-edge research. MMBIO faculty members come from excellent and diverse training backgrounds, with research emphases ranging from host-microbe interactions and pathogen detection, to DNA packaging and metabolic sensing. MMBIO graduate students have remarkable opportunities to learn current research methods and drive the discovery process.

Course work and research that emphasize the integration of molecular biology, developmental biology, biophysics, neuroanatomy, neurophysiology, neuroendocrinology, neuroimmunology, cognition, and behavioral neuroscience is offered through this PhD degree program. Students are required to develop a strong background in the principles of neuroscience and develop the intellectual background and technical expertise necessary for successful research projects in their area of specialization. Eventual publication of the research in peer-reviewed journals is expected but not required. A sound understanding of current concepts in neuroscience is the purpose of the MS degree program. The thesis research project teaches the fundamentals of scientific inquiry and trains students in state-of-the-art research techniques. Submission of the thesis to a peer-reviewed journal is encouraged but not required.
Graduate programs in the department of Physiology and Developmental Biology offer research training and classroom instruction in a wide range of areas pertaining to these disciplines. A biophysics research group is also part of the department. Areas of research include neuroendocrinology and reproduction, endocrine and immune interactions, development of the central nervous system, hereditary connective tissue disorders, mouse and chick models of development, exercise physiology and glucose metabolism, membrane transport and channel structure, synaptic vesicle recycling, and blood pressure control by the autonomic nervous system.

Admission to graduate programs at BYU requires a bachelor’s degree, GRE scores, statement of intent, and letters of recommendation.

Graduate tuition: $3065/semester for members of the Church of Latter-Day Saints; $6130/semester for non-members. PhD students are eligible for assistance in the form of teaching and research assistantships, as well as tuition and health care reimbursement. All students are eligible for scholarships and loans.

Statistics:
Applied 11,238
Admitted 7,055 63%
Enrolled total 5,624
Full Time: 5,545
Part Time 79

Standards:
Test 25th % 75th %
SAT Reading 570 680
SAT Math 580 680
SAT Writing 540 650
ACT Composite 26 30
ACT English 26 32
ACT Math 25 31
ACT Writing 0 0

Retention / Graduation:
Retention rate 87%
4-year graduation rate 30%
6-year graduation rate 77%

Undergraduate Programs and Majors:
Bioinformatics (BS)
Biological Science Education (BS)
Biology (BS)
Conservation Biology (BS)
Microbiology (BS)
Molecular Biology (BS)
Neuroscience (BS)
Physiology and Developmental Biology (BS)

Graduate Programs:
Biological Science Education (MS)
Biology (MS/PhD)
Microbiology (MS/PhD)
Molecular biology (MS/PhD)
Neuroscience (MS/PhD)
Physiology and Developmental Biology (MS/PhD)

Application Deadlines:
Undergraduate: December 1st, early admission; February 1st, regular admission. Applications can be completed online at: http://besmart.com/
Graduate: December 15th for early consideration; all applications are due by February 15th. Applications can be completed online at: http://graduatestudies.byu.edu/

Basic Information:
Founded in 1829, Rochester Institute of Technology is a privately endowed, coeducational university with nine colleges emphasizing career education and experiential learning. The campus occupies 1,300 acres in suburban Rochester, the third-largest city in New York state. RIT also has international campuses in Eastern Europe and Dubai. The RIT student body consists of approximately 15,000 undergraduate and 2,900 graduate students. Enrolled students represent all 50 states and more than 100 countries.

RIT is an internationally recognized leader in preparing deaf and hard-of-hearing students for successful careers in professional and technical fields. The university provides unparalleled access and support services for the more than 1,300 deaf and hard-of-hearing students who live, study, and work with hearing students on the RIT campus.

Undergraduate Programs:
In the College of Science, biology is something that students do, rather than something they merely learn. The courses present biology as it is done by career biologists, and they emphasize hands-on laboratory and field experience. Scientific knowledge is based on research, and we encourage students to undertake research projects in the laboratories of our faculty. The biology program prepares students for rewarding positions in occupations related to the life sciences, including biomedical research, scientific management, science journalism, forensic science, ecology and environmental science, agriculture, genetic counseling, and education. The program includes all of the course work and support services to prepare students for entrance into schools of medicine, dentistry, veterinary medicine, optometry, podiatry, and chiropractic medicine. Graduates are well-prepared to pursue a master’s or doctoral degree in a wide variety of fields in the life sciences.

The Bachelor of Science degree in Biomedical Sciences consists of a Life Sciences Core combined with a broad range of flexible elective options. The Life Sciences Core is designed to provide the student with a strong grounding in mathematics and science with a complement of liberal arts in preparation for a particular career path, e.g., for entry into medical/dental school, into graduate studies, or directly into a research position in an applied area of biomedical science.

Bioinformatics lies at the interface of cutting edge science and next-generation technology, enabling discoveries that were unattainable only a few years ago. Bioinformaticists analyze the massive data sets coming out of modern biological experiments such as Next Generation Sequencing, Proteomics, Metabolomics, and Ecoinformatics. Despite occupying this vital position, formal opportunities for education in Bioinformatics are limited. Those programs that do exist are challenging because they require students to achieve a deep understanding of both the biological processes being studied and the computational approaches needed for data analysis. Nevertheless, in the supportive environment provided by the Thomas H. Gosnell School of Life Sciences at RIT, our highly motivated students thrive in their studies and go on to attend top ranked graduate schools or enter the workforce in pivotal discovery positions in the pharmaceutical, vaccine development and academic research communities.

Students who enroll in the biochemistry major often have an interest in combining the life and health sciences with a chemistry degree. Students take a year of general biology, in addition to a typical chemistry curriculum. During the upper-level years, students take a substantial core of courses in biochemistry, physical chemistry, liberal arts, and elective courses in life sciences. Students must take a minimum of two upper-division biology electives. Employment opportunities for biochemistry graduates exist in the chemical, pharmaceutical, agricultural, forensic, and rapidly expanding biotechnological fields. Graduates also are well-prepared to enter advanced degree programs in biochemistry, medicine, pharmacy, dentistry, and veterinary medicine.

The BS degree in biotechnology and molecular bioscience prepares students to immediately assume challenging positions in research, development, and management in biotechnology. Students are also well-prepared for positions in the fields of plant biotechnology, human genetics, agriculture, food products, pharmaceuticals and vaccine development, environment and energy, forensic science, and genetic counseling. The advanced nature of the third- and fourth-year courses, as well as the opportunity to participate in faculty-sponsored undergraduate research, provides a sound foundation to those graduates wishing to pursue a master’s or doctoral degree. The program also can be designed to include the education necessary for the pursuit of a career in a medical field. Specialized areas of emphasis include recombinant DNA, microbial and plant genetic engineering, mammalian and plant tissue culture, monoclonal antibody production and purification, large-scale fermentation techniques (bacterial and mammalian cell), and methods for characterization and separation of proteins and nucleic acids in yeast, bacterial, viral, and plant systems.
Undergraduate tuition: $31,584/year. cc

Graduate Programs:
RIT’s graduate program in Medical Illustration is one of only five such programs in North America and the only program in the Northeastern U.S.. The two-year program combines training in human anatomy (with complete cadaver dissection), histology (the cellular structure of organs), and pathophysiology (the study of disease) with extensive training in 2D and 3D digital graphics, interactive media, and animation. Illustration projects are designed for use in print, projection, broadcast media, and distribution via the web and mobile devices. The program emphasizes visual problem solving, determining the best approach to communicate a difficult concept. Students also gain real world experience collaborating with medical researchers and observing live surgery in the operating room. The program culminates with the production of a thesis project, which requires extensive background research and an original body of artwork on a complex medical topic.

The master of science degree in bioinformatics provides students with a strong foundation in biotechnology, computer programming, computational mathematics, statistics, and database management. Graduates of the program are well-prepared for careers in the biotechnology, bioinformatics, pharmaceutical, and vaccine industries. Based on consultation with individuals within the industry nationwide, the job market is rich with opportunities for those who obtain a graduate degree in bioinformatics, particularly when coupled with industry-sponsored research as thesis work. This research provides exposure to real-world problems—and their solutions—not otherwise attainable in an academic setting. The program provides students with the capability to enter the bioinformatics workforce and become leaders in the field. The curriculum is designed to fulfill the needs of students with diverse educational and professional backgrounds. Individuals entering an MS program in bioinformatics typically have degrees in biology, biotechnology, chemistry, statistics, computer science, information technology, or a related field. The program is offered on a full- or part-time basis to fulfill the needs of traditional students and those currently employed in the field. Admission requires a bachelor’s degree, GRE scores, letters of recommendation, and a personal statement.
Graduate tuition: $34,659/year. Financial aid is available in the form of grants, scholarships, and loans.

Statistics:
Applied 15,806
Admitted 9,266 59%
Enrolled total 2,678
Full Time: 2,669
Part Time 9
Standards:
Test 25th % 75th %
SAT Reading 530 650
SAT Math 570 680
SAT Writing 520 630
ACT Composite 25 30
ACT English 0 0
ACT Math 0 0
ACT Writing 0 0

Undergraduate Programs and Majors:
Biomedical Sciences (BS)
Biology
Biotechnology & Molecular Bioscience
Biotechnology & Molecular Bioscience with Bioinformatics Option
Bioinformatics
Environmental Science
Biochemistry

Graduate Programs:
Medical Illustration
Bioinformatics (MS)

Dual Degree Programs:
Biology or Biotechnology with MBA (BS and MBA)
Bioinformatics 4+1 BS and MS

Application Deadlines:
Undergraduate: December 1st, early decision; February 1st, regular decision. Application available at: http://www.rit.edu/emcs/admissions/apply...plication
Graduate: February 15th. Application available at: http://www.rit.edu/emcs/ptgrad/grad_admission.php

Genentech Inc. is a biotechnological firm that was founded in the year 1976. This company is also known as the Genetic Engineering technology and its founder is Robert A. Swanson, a venture capitalist and Dr. Herbert Boyer, who is a biochemist. Herbert Boyer is believed to have initiated the recombinant DNA technology.

Genentech Inc has been a member of the Roche group since the year 2009.

Popular biotech products
Genentech Inc. takes into consideration the human genetic information for development of therapeutic products for treatment of life threatening disease conditions. The following is a list of biotech products developed by this firm:
• Actemra
• Activase
• Anaprox
• Avastin
• Boniva injection
• Boniva tablets
• Cathflo activase
• CellCept
• Cytovene
• EC-Naprosyn
• Erivedge
• Fuzeon
• Herceptin
• Invirase
• Kadcyla
• Klonopin
• Kytril injection
• Lucentis
• Naprosyn
• Nutropin AQ
• Pegasys
• Perjeta
• Pulmozyme
• Rituxan
• Rocephin
• Roferon
• Romazicon
• Tamiflu
• Tarceva
• TNKase
• Valcyte
• Valium
• Xeloda
• Xenical
• Xolair
• Zelboraf
• Zenapax

Latest discoveries
Genentech Inc. develops products for severe medical disease conditions. The following is a comprehensive list of molecules that has been developed by the firm.
• AKT inhibitor for treatment of gastric cancer, prostate cancer and solid tumors.
• Anti CD22 and Anti – CD79b antibody drug conjugate indicated in conditions of hematologic malignancies, Non- Hodgkin’s lymphoma and diffuse large β – cell lymphoma.
• Anti – ETBR antibody drug conjugate indicated in treatment of melanoma.
• Anti-HER3/EGFR DAF MAb indicated in treatment of colorectal cancer, head and neck cancer and metastatic epithelial cells.
• Anti-PDL1for treating solid tumors and metastatic melanoma.
• Anti – STEAP 1 antibody drug conjugate for treating prostate cancer.
• Antibody drug conjugate for treatment of multiple myeloma, pancreatic and ovarian cancers.
• Crenezumab for Alzheimer’s disease
• Ocrelizumab for relapsing and progressive multiple sclerosis
• Rontalizumab for systemic lupus erythematosus
• Tofoglifozin for type 2 diabetes
• Mew molecular entity for infectious disease, cytomegalovirus disease in kidney transplant cases
• Ranimizumab for age related macular degeneration
• Anti – PCSK9 indicated for cardiovascular diseases.

Recent company takeovers
Genentech Inc. believes in partnering with organizations for expanding their business which in a way helps widening their areas of research. The firm’s relationship with Roche is a unique one. These two firms have two independent R&D organizations and with separate budget allocations.
The firm collaborates with other organizations to conduct research in the areas of immunology, cardiovascular disease, oncology, neuroscience, ophthalmic disease, therapeutic lead discovery technologies and biomarker assay technologies.

Apart from these, the firm has partnered with the following organizations:
• Array Biopharma Inc
• Seattle Genetics ADC technology
• Abbott laboratories
• Exelixis
• Piramed Ltd.
• NovImmune
• AC Immune SA

Work culture
The work culture at Genentech Inc. is very vibrant and at the same time positive. The firm regards its employees as its success pillars and considers them as assets. Its employees are appreciated and handsomely rewarded for their achievements and success. It has several benefit programs to financially secure their employees after retirement.
The employees of this firm are very hard working and leave no stone unturned for churning out products that would help fight life threatening disease. The employees strive very hard to develop therapeutic products that will be beneficial for the world at large.

Interesting events
Genentech Inc. with its constant research and breakthrough technologies is always in the limelight. The following is the list of events that would confirm the above mentioned statement.
• The drug Obnituzumab developed by Genentech was found to be much more effective than Rituxan in decreasing the disease progression in individuals with blood cancer.
• The FDA has given the go ahead for priority review of Obnituzumab for patients who have not been treated for CLL – Chronic Lymphocytic leukemia.
• The FDA has also granted permission for priority review of the drug Perjeta Regimen to be used before surgery in patients with HER2 – positive early stage breast cancer.
• The drug Avastin along with chemotherapy showed to improve the survival rate in women suffering from advanced stage of cervical cancer.
• The firm announces the phase III results of Avastin. This drug is administered to patients with aggressive forms of brain cancer. It is proposed to be given in conjunction with either chemotherapy or radiotherapy.

Recent job openings
The firm is always on the hunt for dynamic and experienced individuals who would take the firm to new higher avenues. As of now there are about 459 job openings in this firm. Listing all the openings will be difficult and therefore a few of the latest job openings have been given below. For more information interested candidates can log on to the company’s website and can also drop in their resume @genentechjobs.
• CCM manager / Senior manager, manufacturing Bioprocess: The individual would be solely responsible for handling the team and execution of the tasks. They are also responsible for executing 24 x 7 large scale media preparation and cell culture operations. Interested candidates need to have at least 9 years of experience in operations and 5 years of experience in leadership and management positions.
• Scientist – Protein analytical chemistry: The individuals are responsible for analytical characterization of recombinant proteins. The individuals also need to be an active participant in project teams and may also have to handle 2 - 4 research associates. The individual need to be doctorate in analytical chemistry, biochemistry and chemical engineering.
• Senior principle technical manager, external quality validation, steriles (Brazil): Individuals have to provide oversight validation and also assess validation of methodologies at CMPs. They need to have a graduation degree and have experience of at least 7 – 10 years in quality or validation. They should also possess strong knowledge of the global pharmaceutical and biotechnology industry.
• QC Associate II – Biological technologies: These individuals should have a graduate degree in BA or B.S and should possess strong communication skills. They should also have expertise in handling HPLC and additional knowledge in analytical technologies would be an advantage.

Celera Corporation, founded in the year 1998, is a firm devoted to health care business. Molecular diagnostic products are developed and manufactured by this company to be used by the clinical laboratories and hospitals to detect, manage and treat disease conditions. The firm has joined hands with Abbott Laboratories for distribution and commercialization of various molecular diagnostic products developed by it.

In the year 1998, the firm was a business unit of Applera. From there it grew up to be an independent company in the year 2008. Three years hence, the company was finally acquired by Quest Diagnostics in 2011.
It is a member of NASDAQ and is traded under the name of CRA.

Popular biotech products
Celera Corporation develops products for treatment of infectious diseases such as HIV. One of its popular products in this regard is the ViroSeq HIV-1 genotyping system that is meant for detecting HIV genomic mutations. This product has also been proved to be useful for managing patients with HIV-1 in whom the drug therapies have failed to show the desired effect.

The next most effective product is a diagnostic device developed for diagnosing the genotyping assay in cystic fibrosis. This device is named as the cystic fibrosis genotyping assay. This innovative device can also be used as a new born screening tool, career screening in adults of reproductive age group and as a confirmatory diagnostic tool in children and newborns.

The AlleSEQR HLA PCR/sequencing kits and AlleSEQR Heterozygous Ambiguity Resolution Primers are developed to provide high resolution identification of human alleles.

Latest discoveries
The Celera Corporation is constantly making new discoveries in the area of both diagnostic tools as well as pharmaceutical products. The firm carries out deep studies in several disease areas such as coronary heart disease, thrombosis, lung disease, liver diseases, CNS, breast cancer, stroke and autoimmune disorders.

Recent company takeovers
Celera Corporation is ever ready to partner with several other firms for expanding their business which would in a way also help widen their areas of research. The company invites those firms that wish to partner for a long term relationship and also those who are interested in great scientific research and positive patient outcomes. Interested firms can contact them at Alliancemanagement@Celera.com for a prosperous and long term future with Celera Corporation.

Work culture
The work culture at Celera Corporation is vibrant and offers very positive environs for its employees. The company is a powerhouse of passionate individuals who can go to any extent to deliver the best diagnostic tools and pharmaceutical products to the world. Not just this, the company also rewards its employees for their excellent performance at work both financially as well as securing their future through several beneficial packages.

Interesting events
Celera Corporation has joined hands with Abbott laboratories for marketing Celera’s CE – marked KIF6 diagnostic test kit. This diagnostic test kit will detect the genetic marker that is associated with individuals who are at a risk of falling prey to coronary heart diseases.
Celera Corporation has signed a license agreement with the University of California and has given rights to conduct in – house test for the KIF6 gene test kit in their laboratories. It would be the first time that such a test will be performed outside the Corporation.

Recent job openings
Celera Corporation is always on the lookout for individuals who with their research skills can take the company to new avenues. Job openings are available and individuals need to apply for the specific job based on their experience and educational qualifications. A job id has been provided against all the jobs and the individuals need to apply accordingly. Below is a list of recent job openings.

Job title | Location
Rep, Phlebotomy Services - position in client office in Goldsboro | 1006a W H Smith Blvd
Analyst, Workforce - NOC- Tampa, FL | 4225 E Fowler Avenue
Rep, Client Service I - Lenexa, KS | 10101 Renner Blvd
Rep Phlebotomy Service - CA | 15 Altarinda Rd
Route Service Rep - Gainesville, FL - M-F 11am-7:30pm (2nd shift) | 825 NorthWest 23rd Ave.
Technician, Medical II - in client office position located at our Cary facility | 201 Commonwealth Ct
Rep, Phlebotomy Service - in client office position located in Columbia area | 3010 Farrow Road
Group Lead, Phlebotomy Service | 14050 Town Loop Blvd
Floater, Phlebotomy Service - covers the Winston-Salem Patient Services territory | 3726 Vest Mill Road
Rep, Phlebotomy Services - in client office position located in the Cumming area | Multiple Locations
Rep, Phlebotomy Svcs - Part-Time 25 hours/week - Winter Springs, FL | 1132 E. State Road 434
Analyst, Workforce - NOC - Lenexa, KS | 10101 Renner Blvd
Rep, Phlebotomy Services | 750 W Plymouth Ave
Rep, Phlebotomy Services (30 hr position) | 4509-009 St. Johns Avenue
Rep, Route Service - Miramar, FL - 2nd shift - Mon-Sat | 10200 Commerce Parkway
Rep, Phlebotomy Service - in client office position located in St Simmons area | 6555 Abercorn St
Mgr, Reporting Administration & Development - Collegeville, PA | Collegeville Main
Senior Database Administrator | MedPlus REMOTE - Nationwide
Hospital Account Executive - Washington, DC | 1901 Sulphur Spring Road
Oncology Account Manager - Orlando, FL | 541 E.Horatio Ave
Accounting Intern - MedPlus | 4690 Parkway Drive
Senior Database Administrator | MedPlus REMOTE - Nationwide
Rep, Phlebotomy Services II, West Mifflin PA area, MTh 4a-12:30p, T,W,F 6a-12:30p, plus rota Sat | 1907 Lebanon Church Road
Rep, Phlebotomy Svcs I - CA | 1600 Creekside Drive
Technician, Specimen I, Night Shift 8:30pm -5am, M-F - 40hrs/week | 875 Greentree Rd
Rep, Phlebotomy Services II, Tonawanda NY area, F/T 38hrs/wk, M-F 7:00a-2:30p, plus rot Sat 7a-12p | 2173 Sheridan Dr
Rep, Phlebotomy Services - Norman, OK | 950 N. Porter
Clinical Lab Supv - Hematology (nights) - Miramar, FL | 10200 Commerce Parkway
Rep, Route Service I - TEMPORARY (Teterboro, NJ) | One Malcolm Ave
Rep, Phlebotomy Svcs I - CA | 450 Kings County Dr
Floater, Phlebotomy Svcs - CA | 919 N Blackstone St
Rep, Phlebotomy Svcs II - (P/T), Norton OH area, 20hrs/wk, M-F(9a-1p) | 2451 Edison Blvd
Rep, Phlebotomy Svcs I - CA | 919 N Blackstone St
Asst, Pre-Analytical I, NIGHTS - M-F 10pm-6:30am, plus rotating Saturdays | 875 Greentree Rd
Route Service Rep - Part-Time 25 hrs/wk - M-F 10am-3pm | 592 Ellis Rd.
Rep, Cust Svce - 9am-6pm Tampa | 3011 University Center Drive

Basic Information:
The University of South Florida is a high-impact, global research university located in beautiful Tampa Bay on Florida's spectacular west coast. It is one of the largest public universities in the nation, and among the top 50 universities, public or private, for federal research expenditures. The university is one of only four Florida public universities classified by the Carnegie Foundation for the Advancement of Teaching in the top tier of research universities, a distinction attained by only 2.3 percent of all universities.

With over 230 degree programs at the undergraduate, graduate, specialty and doctoral levels, including the doctor of medicine, there's something for everyone at USF. The university offers a dynamic learning environment that inspires innovation, creativity and collaboration and is focused on student success. More than 2,000 distinguished scholars, researchers and expert teachers, nearly all holding PhDs or the highest degrees in their fields, make up the USF faculty – including the 2012 U.S. Professor of the Year.

At USF Tampa, over 30,400 undergraduates, more than 8,400 graduates, over 550 Doctor of Medicine candidates and more than 1,500 non-degree-seeking students make up the total campus enrollment of over 41,000. The students are a diverse group, coming from every state, every U.S. territory and more than 150 countries around the world. International students make up 5 percent of the total student population.
Students at USF Tampa, are high academic achievers. New freshmen for the Fall 2012 semester had an average high school GPA of 3.94, an average SAT score of 1209, and average ACT score of 27. Fifty percent of new freshmen graduated in the top 20 percent of their class, and 86 percent are Bright Futures Scholarship recipients. Twenty-five students in the 2012 freshman class are National Merit Scholars, four are National Achievement Scholars and 15 are National Hispanic Scholars.
The university's faculty are world-class scholars. Instructional faculty at USF Tampa number more than 1,500. Eighty-six percent of full-time faculty hold terminal degrees in their field. The university has 50 endowed chairs and 30 endowed professorships.

Undergraduate Programs:
The school of biological sciences at the University of South Florida offers undergraduate degrees through two divisions, the division of Cell Biology, Microbiology and Molecular Biology and the division of Integrative Biology. The Department of Cell Biology, Microbiology and Molecular Biology (CMMB) has responsibility for the education of undergraduate students in core cell biology, molecular biology, genetics and microbiology topics as well as more specialized areas that require detailed knowledge of these subjects. To accomplish this mission, CMMB offers curricula that will lead to Bachelor of Science degrees in Biology and Microbiology. Courses are designed to meet the needs to students majoring in other science disciplines as well as non-science areas. The CMMB faculty members are dedicated to excellence in this mission.

Research and teaching in the Cell Biology, Microbiology and Molecular Biology division emphasizes cellular processes in prokaryotes and eukaryotes with an increasing focus on biotechnology and preparing students for professional careers in the areas of cell biology, microbiology and molecular Biology. Faculty research interests include: Molecular pathogenicity and antibiotic resistance of microbes; structural and computational biology; the biology of aging, gene expression and genomic instability.

Research and teaching in the Integrative Biology Division emphasizes organismal interactions and adaptations to the environment. We take a modern interdisciplinary approach to understand the interactions at many levels from cells to organisms to populations to communities to landscapes. Faculty research interests include: marine and freshwater ecology; restoration ecology; population ecology; plant-animal interactions; community ecology; plant systematics; conservation biology; ecotoxicology; biomechanics and functional morphology; environmental microbiology; microbial physiology; and gene transfer.

The department of chemistry offers a bachelor’s degree in biomedical sciences. Biomedical Sciences is designed to fulfill many of the admissions requirements for professional schools in the Health Sciences (e.g. Medicine, Pharmacy, Dentistry). Students contemplating graduate study should pursue a major in the discipline of their interest, such as Biology, Chemistry, or Microbiology.

Undergraduate Tuition: $211.19/credit hour resident; $575.01/non-resident. Financial aid is available in the form of grants, scholarships, and loans. Students should complete the FAFSA to be eligible for financial aid.

Graduate Programs:
The Department of Cell Biology, Microbiology, and Molecular Biology offers master’s degrees and doctoral degrees in Cell and Molecular Biology. The master’s degree can either be thesis based or non-thesis based. They also offer a non-thesis based master’s degree in microbiology through the department.

The Biomedical Engineering Initiative represents a joint venture between the College of Medicine and College or Engineering. This initiative is a natural extension of the current biomedical engineering expertise present at USF, and will serve and enhance the development of the large cluster of more about 300 businesses that manufacture medical products in the region. The Initiative is designed to leverage the strengths of the region's related enterprise to create innovative and novel solutions, technologies and products that address current societal needs and improve the quality of life for Florida's citizens.

The M.S. pre-professional program in Medical Sciences, within the College of Medicine, has been developed to provide a novel interdisciplinary and concentrated program of study that is designed for students interested in either future doctoral or professional programs in the biomedical sciences and who value the interdisciplinary approach. The program integrates several disciplines and topics including the subject areas of anatomy, biochemistry, genetics, histology, microbiology, neuroscience, pathology, pharmacology and physiology. These medically-oriented subject areas have been integrated to provide a solid foundation in the medical sciences. The rigorous program is designed to allow students to demonstrate their full academic ability and suitability for future careers in healthcare in either academic or clinical environments. The interdisciplinary nature of the program promotes a broad intellectual focus that is required of current and future health-care professionals. In addition to the typical subject matter, the majority of the courses integrate modern teaching methods with extensive student participation designed to improve their written, oral and presentation skills that are also important components of their future professional development. Graduates of the program are anticipated to continue their professional development at medical and dental schools together with a variety of other healthcare professional programs. Students in this track take selected pre-clinical medical school courses and are able to complete the requirements for a Master of Science degree in Medical Sciences within one year.

The M.S. research program in Medical Sciences, within the College of Medicine, offers several concentrations, which consists of basic/molecular science credits, with medical relevance. This program is designed to prepare students for future educational or research endeavors in graduate education or other professional programs.

Graduate Tuition: $431.43/credit hours residents; $877.17/credit hour non-residents. Graduate students are eligible for financial assistance in the form of research and teaching assistantships, as well as through fellowships.

Graduate admission requires a minimum B average for undergraduate work, as well as GRE scores, and letters of recommendation.

Undergraduate Programs and Majors:
Microbiology (BS)
Cell Biology, Microbiology, and Molecular Biology (BS)
Integrative Biology (BS)
Biomedical Science (BS)

Graduate Programs:
Cell and Molecular Biology (MS/PhD)
Microbiology (MS)
Biomedical Engineering (PhD)
Medical Science (PhD)
Bioinformatics (MS)
Biotechnology (MS)
Bioethics (MS)
One-year Medical Masters (MS)

Dual Degree Programs:
MD/PhD

Application Deadlines:
Undergraduate: Accepted on a rolling basis beginning in October
Graduate: Varies by program; fellowship deadline February 1st
Apply online at: https://secure.vzcollegeapp.com/usf/default.aspx?cid=87&ltid=1

Basic Information:
Yale's roots can be traced back to the 1640s, when colonial clergymen led an effort to establish a college in New Haven to preserve the tradition of European liberal education in the New World. This vision was fulfilled in 1701, when the charter was granted for a school “wherein Youth may be instructed in the Arts and Sciences [and] through the blessing of Almighty God may be fitted for Publick employment both in Church and Civil State.” In 1718 the school was renamed “Yale College” in gratitude to the Welsh merchant Elihu Yale, who had donated the proceeds from the sale of nine bales of goods together with 417 books and a portrait of King George I.

Yale College survived the American Revolutionary War (1775–1783) intact and, by the end of its first hundred years, had grown rapidly. The nineteenth and twentieth centuries brought the establishment of the graduate and professional schools that would make Yale a true university. The Yale School of Medicine was chartered in 1810, followed by the Divinity School in 1822, the Law School in 1824, and the Graduate School of Arts and Sciences in 1847 (which, in 1861, awarded the first Ph.D. in the United States), followed by the schools of Art in 1869, Music in 1894, Forestry & Environmental Studies in 1900, Nursing in 1923, Drama in 1955, Architecture in 1972, and Management in 1974.

Undergraduate Programs:
The undergraduate Molecular Biophysics and Biochemistry degree programs at Yale University are well suited for students planning to attend medical school or graduate studies in biochemistry, molecular biology, genetics, genomics, or biophysics. The MB&B major differs from the programs offered by the Molecular, Cellular, and Developmental Biology (MCDB) department in that MB&B places its central focus on studying biology using the tools of chemistry, physics, and biochemistry. MB&B students thus carry out more in-depth coursework in these areas, and typically take less coursework in other areas such as organismal biology, cell biology, and genetics.

The departments of Ecology and Evolutionary Biology (EEB) and Molecular, Cellular & Developmental Biology (MCDB) offer the major in biology jointly. Each department offers an area of concentration within the major that reflects its perspectives and approaches to research while allowing students flexibility in drawing electives from both departments. There are also two interdisciplinary tracks - in biotechnology and neurobiology - offered within the MCDB area of concentration. The major offers B.A., B.S., intensive B.S., and combined B.S./M.S. programs, the latter two for students who wish to devote more time to research.

Upper level undergraduate students in Biomedical Engineering select from classroom experiences in engineering, biology, and medicine and are introduced to independent research projects through one or more semester-long “Special Projects,” which are designed together with faculty advisors. Juniors will take core courses on the fundamentals of Biomedical Engineering, focused on mathematical modeling of transport processes and physiological systems. They will also take a full-year laboratory covering a number of current topics in the field. In addition, students will take at least three courses in a particular track (biomedical imaging, biomechanics, and biomolecular engineering), as well as a Senior Seminar to give them a broader perspective of the fields. Finally, it is important to note that as part of their Senior (Special) Project, Yale Biomedical Engineering students will select from research projects that combine Engineering and clinical medicine to address a range of important problems with direct impact on human health care.

Undergraduates must submit test scores from either the SAT and any two subject tests; or the ACT plus writing test. There are no score cutoffs for standardized tests, and successful candidates present a wide range of test results. During the most recent year, test score ranges (25th to 75th percentiles) for enrolled freshman were:

SAT-Verbal: 710-800
SAT-Math: 710-790
SAT-Writing: 720-800
ACT: 32-35

Graduate Programs:
The Yale Combined Program in the Biological and Biomedical Sciences (BBS) is a doctoral program that enables you to take advantage of all of the resources found at a modern research university. Everything Yale has to offer – faculty, facilities, and campuses - is here in one comprehensive, interdisciplinary graduate program. Tracks in the Biological and Biomedical Sciences program include: Biochemistry, Biophysics, and Structural Biology; Computational Biology and Bioinformatics; Immunology; Microbiology; Molecular Cell Biology, Genetics, and Development; Molecular Medicine, Pharmacology, and Physiology; and Neuroscience. BBS has no boundaries, either departmental or geographical. Upon admission to Yale you will have access to courses, seminars, and faculty labs in every department. Because Yale is unusual among major universities in having its main campus and medical school within walking distance of one another, you can easily participate in research activities and courses on the main University campus as well as at the world-renowned Yale School of Medicine. Moreover, Yale’s brand new West Campus is connected to the rest of the university by non-stop shuttle service.

The Biomedical Engineering graduate program started in 2000 and immediately became a popular area of study. Doctoral studies in Biomedical Engineering consist of two years of course work and of original research. The PhD program has a teaching requirement, and therefore English speaking proficiency is a requirement. The TOEFL test is required for applicants with a Bachelor’s degree from a university where English is not the primary language of instruction. It is common for incoming PhD students to score 100 or higher on the TOEFL test overall and 26 or higher on the TOEFLSpeaking test, or 7 or higher on the IELTS. PhD candidates in BME have their tuition paid and receive a stipend for living expenses (~$2500 per month). Funding comes from the University for the first year, followed by support from the primary mentor, unless the student brings his/her own funding.

Doctoral students with a concentration in Biostatistics are prepared for conducting the following types of research in health or medicine: the design of comprehensive investigations; the novel employment of existing statistical methods to address meaningful scientific questions; the development of new statistical methodologies with immediate application to studies of the cause or treatment of disease. Applicants should have knowledge of the principles of biology and a strong undergraduate record in mathematics, including course work in advanced calculus and linear algebra. A master’s degree is not required to apply for this program. Since 1999 the Department of Biostatistics has also offered an MS in Biostatistics designed to train students to meet the growing need in managed care organizations, medical research, and the pharmaceutical industry for graduates with technical skills in data analysis. As opposed to the more general MPH degree, the MS degree, now known as the MS in Public Health in the Biostatistics track, emphasizes the mastery of biostatistical skills from the beginning of the plan of study. Graduates of this program may apply to the PhD degree program.

Other Information:
Undergraduates: 5,349 (2012)
Ranking: #3 National University (2012)
Acceptance rate: 7.70% (2012)
Tuition: $42,300 USD (2012)

Undergraduate Programs and Majors:
Molecular Biophysics and Biochemistry (BS)
Biology (BS)
Biomedical Engineering (BS)

Graduate Programs:
Biological and Biomedical Sciences (PhD)
Molecular Biophysics and Biochemistry
Biomedical Engineering (MS/PhD)
Biostatistics (MS/PhD)
Physiology (MS/PhD)
Genetics (MS/PhD)
Immunology (MS/PhD)
Microbial Pathology (MS/PhD)

Application Information:
To be accepted to study at Yale, interested applicants must apply directly to the school, college, or program where the degree will be awarded: Yale College for undergraduate degrees; the Graduate School of Arts and Sciences for doctoral programs and some master’s degrees; or one of the professional schools.

Undergraduate deadline: November 1st, single-choice early admission; December 31st, regular admission

Graduate deadline: December 1st

Mylan is a generic and pharmaceutical company, serving over 140 countries and territories. It develops and manufactures products for life threatening disease conditions such as AIDS. It is one of the leading manufacturers of API which is indicated for making generic antiretroviral (ARV) therapies for treating HIV/AIDS.

One of the most basic and important principles of this firm is to market the drugs at a low cost. This had made possible treating HIV / AIDS amongst those communities where affording the medicine was really difficult. Making available the drugs at low cost has helped about one third of all the individuals receiving treatment for HIV/AIDS.

The firm has basically 3 functional areas namely: generics, active pharmaceutical ingredients and medical devices. Mylan laboratories have its business spread overseas in North America, Europe, Middle East, Asia Pacific and Africa. It is a member of NASDAQ and is traded as MYL.

Popular biotech products
Mylan laboratories is one of the largest producer of API that is used in a variety of categories such as agents in central nervous system, anti histamines, anti asthmatics, anti vials, anti diabetics, anti fungal and proton pump inhibitors. The API is also made use of in drugs for pain management.

Latest discoveries
Apart from being the leading producer of API, the firm also has hands on expertise in manufacturing generic antiretroviral (ARV) products. These products help in the treatment of people with HIV / AIDS. Mylan laboratories also develop finished products of ARVs and pediatric therapies. The firm is also on its way of developing and manufacturing newer methods and therapies for combating deadly and life threatening diseases like AIDS.

Recent company takeovers
Collaborations and partnerships with several firms have always been of benefit to both parties. It allows them to expand their research areas which also have a direct impact on the business revenues. Mylan laboratories and world team tennis joined hands in the year 2011 for a period of 3 years and signed an agreement that would serve as a title sponsor for WTT. Pfizer and Mylan also entered into a collaboration in the year 2012 that would witness the growth of generics in Japan. This collaboration will produce about 350 marketed products along with 125 products that will include wide range of therapeutic areas.

Work culture
The work culture at Mylan laboratories is very positive and they believe in team work. The employees of this firm have the capacity to even move mountains if required. They are hard working and leave no stone unturned to furnish out the best therapies for treating life threatening disease conditions. The workforce of this company are mission oriented – they believe in service, service to the world by delivering the best medical devices and therapeutics for the world at large.

Interesting events
Mylan laboratories with their hard work and consistent efforts have always been in the public eye. They have tried very hard to make impossible tasks possible. The following are some of the interesting events for the year 2013 showcasing the skills of the firm.
• The firm announced the STALEVO and TARCEVA settlement agreement.
• The firm got approval for Buproprion hydrochloride extended release tablets.
• The firm announced the completion of transdermal patch facility expansion project.
• The firm will address the gathering at the Bank of America Merill Lynch Global Healthcare Conference and Morgan Stanley Global Healthcare Unplugged Conference on the 5th of September.
• In the month of July, Mylan launched the Generic Nor – Q.D. tablets. The same month witnessed the launch of the first generic version of trilipix capsules.
Recent job openings
The firm is always on the lookout of hardworking individuals who with perseverance and research skills can take the company to new defined avenues. Following is a list of job openings at Mylan. Each job opening has been provided with the respective id and interested individuals can apply accordingly.

Sr. no. - Job title
1 - Supervisor, QA Admin
2 - IT provider commercial portfolio lead
3 - Scientist, Chemistry
4 - Supervisor
5 - Quality assurance in process supervisor
6 - Lead specialist, business process owner, manufacturing
7 - Senior IT project manager
8 - Director Global operations finance
9 - Senior director, manufacturing solutions
10 - Validation analyst
11 - Director, NA compensation and benefits
12 - Senior site core developer
13 - Executive assistant
14 - Senior QMS software engineer
15 - HRIS analyst
16 - Manager, global finance
17 - Chemist
18 - Senior director, partnering finance programs
19 - Director, global benefits
20 - senior director, sales training
21 - Finance Technology Business Analysis Principal
22 - Global R&D Operational Project Manager
23 - 2014 Summer Finance Internships
24 - Administrative Manager
25 - Scientist
26 - Administrative assistant
27 - Technical area lead
28 - Senior Manager, Advertising Promotions, Regulatory Affairs
29 - Scientist, quality
30 - Manager, Global Quality Compliance SWAT
31 - Weekend Master Mechanic
32 - Senior Accounting Assistant
33 - Engineer, Global IT Infrastructure Services
34 - Quality Assurance Supervisor
35 - Senior Associate, Pricing and Contracts
36 - Supervisor, Production Maintenance
37 - Scientist
38 - Regulatory Affairs Specialist CMC
39 - Administrative Assistant
40 - QA Review Associate, 2nd
41 - Legal Secretary - Legal Operations
42 - Senior Review Chemist
43 - Product Safety Specialist
44 - Senior Product Safety Specialist
45 - Technical Group Leader, NA R&D Technical Services
46 - Clerk, Sorting & Scanning
47 - Internal Audit Staff
48 - Associate, Regulatory Affairs
49 - Senior Scientist

Interested candidates can drop in their resume at the company’s website clearly mentioning the post they wish to apply for along with the job id. Candidates are also advised to search and take a short tour of the company’s website to know in detail about the company and its functioning. In addition to the above mentioned job openings, individuals can also search for other jobs opportunities with this firm and place their application accordingly. They can either fill an online application form or can email the concerned authority.

Bausch and Lomb is one of the leading brands in eye care products founded in the year 1853. It is an American based company that has its headquarters in Rochester, New York. The firm develops and manufactures products for eye care and eye diseases such as contact lenses, lens implants, medications and lens care products. The company has its business spread across 36 countries and has about 13, 000 employees.
Bausch and Lomb was primarily a public company that was listed in NYSE until 2006; thereafter it was acquired by private firm Warburg Pincus PLC in the year 2007.

Popular biotech products
Bausch and Lomb manufacture innovative products for eye care and also develop products for treatment of various eye diseases. The firm’s major expertise is in the area of developing a wide variety of contact lenses that suits several eye types. Below is a list of products developed by the firm:
• Contact lenses for far sightedness, near sightedness, astigmatism and presbyopia.
• Contact lenses for cataract surgery- the brand name is SilSoft which is a specially designed lens that can be used for both children as well as adults. These lenses can be used in situations when intraocular lens cannot be fitted. In majority of the cases, this type of contact lens is the only cure for infantile aphakia.
• Customized soft contact lenses indicated in individuals with keratoconus and irregularly shaped corneas.
• Bausch and Lomb also offer vision shaping treatment, which is a process that corrects the vision of an individual while they are asleep.
In addition to the above mentioned products, the firm also develops several eye vitamins, eye wash, surgical products, vision accessories, safety and industrial cleaning products, pharmaceutical products, products for dry eyes and allergies.

Latest discoveries
Bausch and Lomb is committed to improvise its existing products as well as develop new ones for treating several eye conditions. Of late, the firm launched the first ever vitamin and mineral supplement that is indicated in conditions of age related diseases. This supplement is known to match the standards and formulae as laid down in the National Eye Institute’s Age – Related Eye Disease Study 2 (AREDS2).

Recent company takeovers
Baush and Lomb recognize the importance of collaborations and partnering with various other firms to research and develop new products. Collaborations not only helps widen the areas of research but also helps expand the business prospects.
In the year 2013, the firm joined hands with THERAPEARL to market the novel mask developed by the parent company for providing relief from various types of eye diseases.
In the same year, the firm acquired Options for licensing its new compounds that have been developed for marketing products indicated for treating conditions of dry eyes.

Recent corporate news
In the year 2013, August 5, Valeant Pharmaceuticals International Inc. completed the acquisition of Bausch and Lomb. The name of the firm will however not be changed, and would function as an independent division of Valeant. With this acquisition the ophthalmic division and business of Valeant will get merged with that of Bausch and Lomb and will see a rise in net revenue of more than $ 3.5 billion.
Work culture
The work culture at Bosch and Lomb is very positive and at the same time dynamic. The employees of this firm have the potential of carrying out excellent quality research and do not leave any stone unturned for achievement of the impossible tasks.

Interesting events
The firm with its ever striving attitude to achieve something new is always ready with some innovative solutions for eye care every year. This keeps the firm in the limelight always. The Health Canada Medical device provided license to Bausch and Lomb in this year for VICTUS femtosecond laser platform.
The firm also contributes generously by providing grants to charitable organizations with the mission of helping individuals with eye diseases to have a clearer vision.

Recent job openings
The firm is always on the lookout for individuals with caliber to carry out breakthrough research for developing innovative products for eye care. Bausch and Lomb is an equal opportunity employer and hire individuals irrespective of their race, sex, disability and religion. The firm also has special provisions for individuals with mental or physical disabilities. The following table speaks of the job openings along with their job ids. They can either email the concerned authority or drop their resume at the website and wait for the recruitment process.

Job description -- -- Requisition id
Senior Training Specialist -- -- 8500
Engineering I, Manufacturing -- -- 8483
Team Leader, Manufacturing -- -- 8482
MES Programmer Analyst - Rochester, NY -- -- 8469
MES Programmer Analyst - Rochester, NY -- -- 8469
Manufacturing Supervisor, Filling -Weekend Crew -- -- 8466
Filling machine, technician -- -- 8550
Manager Medical Marketing -- -- 8247
Ocular Specialty Representative -- -- 8545
Quality Associate II -- -- 8536
Quality Inspector -- -- 8543
Lens maker -- -- 8535
Trainer associate II -- -- 8533
Vision care – Territory manager -- -- 8542
Custodian -- -- 8540
Director marketing -- -- 8537
Ocular specialty Rep -- -- 8539
Ocular specialty representative, WI -- -- 8538
Vision care – area sales director -- -- 8520
Vision care – territory manager -- -- 8534
Vision care – sales associate -- -- 8529
Vision Care: Territory Manager - Syracuse, NY -- -- 8494
Ocular Specialty Representative - Indianapolis North (Team-Blue) -- -- 8531
Validation Engineer II -- -- 8525
Ocular Specialty Representative - West Palm Beach FL (Team Blue) -- -- 8530
Production Technician - Pegsus -- -- 8526
Vision Care: Territory Manager - Fort Worth -- -- 8523
Vision Care: Territory Manager - Cedar Rapids, IA -- -- 8518
Ocular Specialty Representative - Birmingham North (White Team) -- -- 8510
Quality Inspector - 1st -- -- 8505
Vision Care: Territory Manager - Alpharetta / Lawrenceville, GA -- -- 8495
Ocular Specialty Representative - Philadelphia, PA (Team White) -- -- 8484
Engineering Controls Technician -- -- 8079
Quality Supervisor, Microbiology -- -- 8472
Ocular Specialty Representative - Washington DC(Team-Blue 1) -- -- 8478
Manufacturing Supervisor, Technical -- -- 8464
MES Programmer Analyst - Greenville, SC -- -- 8453
Surgical: Regional Business Director - Texas -- -- 8071
Surgical: Crystalens Territory Manager: Michigan/Ohio -- -- 8456
Ocular Specialty Representative - Queens, NY (Team White) -- -- 8442
Technician IV, R&D Operations -- -- 8438
Senior Engineer, Systems (Optics Development) -- -- 8407
Canada Customer Service Representative - French -- -- 8397
Surgical Territory Manager - Charlotte, NC -- -- 8392
Production Associate III - Senior Setup Technician -- -- 8076
Senior Engineer, Packaging -- -- 8347
Sr. Equipment Engineer -- -- 8212
Surgical Associate Territory Manager/Northern Virginia -- -- 8289
Manager, Biostatistics (Vision Care R&D) -- -- 8145
Manufacturing Associate I -- -- 8047

Basic Information:
Abraham Lincoln played a significant role in the creation of the premiere public university in his home state by signing the Morrill Act, the legislation that created the land grant university system. At the time of Lincoln's presidency, the United States was rich in land, and Congressman Justin Morrill's legislation gave states millions of acres that could be used or sold to fund state universities. In 1867, Illinois sold 380,000 of its 480,000 land grant acres at 66 cents an acre, raising a little more that $250,000 to fund Illinois Industrial University, which would become the University of Illinois.

Learning and LaborThe first regent (president) of the University was John Milton Gregory. Until Gregory's arrival, many proponents of the new university wanted it to stick to providing a mechanical and industrial education to the state's citizens, who were mostly farmers. Gregory made clear that the university would provide a "liberal and practical education to the industrial classes." In his inaugural address, Gregory stated that the university must offer "a full table spread with every form of human knowledge, and bid (students) freely to the feast." It was largely because of Gregory that the university's Alma Matercurricula was broadened to offer a range of scholarly pursuits for the first class of 77 students, and for generations of Illini.

Illinois is proud of its land grant heritage and continues to strive toward continued realization of the mission mandated with Lincoln's signature: excellence in education, research, and public engagement.

Undergraduate Programs:
The MCB undergraduate curriculum is focused on the fundamental structures, functions, and mechanisms of living organisms. The curriculum provides you with a solid foundation in biochemistry, cell and developmental biology, microbiology, molecular genetics, and physiology and structural biology. You will also develop a strong foundation in math and physical sciences. Incoming Freshmen should apply for admission to the College of Liberal Arts & Sciences (LAS) and choose Biology as your intended major. Freshmen in Biology will take an introductory course in Integrative Biology (IB) and an introductory course in Molecular and Cellular Biology (MCB). Just prior to sophomore year students will consult with an advisor and decide between Integrative Biology and Molecular and Cellular Biology for their final degree program.

Integrative biology is the study of how the different components of life interact, from molecules through global cycles. An Integrative Biology (IB) major, offered by the School of Integrative Biology, provides a solid foundation of knowledge and skills in the biological sciences by preparing students in genetics, physiology and development, behavior, ecology, and evolution. More specific information about the major can be found under For Prospective Students and links found there. The School also offers an IB Honors concentration for superior students seeking an extraordinary education. If you are interested in IB Honors you should see an IB Advisor as soon as possible in your freshman year.

Biochemistry at Illinois is an advanced, interdisciplinary field that encompasses the biological and chemical sciences. Our department is part of the School of Molecular and Cellular Biology and has close ties with the School of Chemical Sciences, the Institute for Genomic Biology, the Center for Biophysics and Computational Biology, the Neuroscience Program, the Medical Scholars Program, and other interdisciplinary groups. A bachelor's degree in biochemistry from the University of Illinois at Urbana-Champaign prepares students for entry into graduate programs in biochemistry, chemistry, molecular biology, or other areas of advanced biology. It will also prepare them for entry into medical, dental, veterinary, or pharmacy school. By majoring in biochemistry at Illinois students are well-prepared to enter positions in the biotechnology, chemical, and pharmaceutical industries.

Recommended high school coursework includes 4 years each of English, Mathematics, Social Sciences, Lab Sciences, and a single Foreign Language.

Undergraduate tuition: $11,847/ year in-state; $27,219/year out-of-state. Financial aid is available in the form of scholarships, grants, loans, and work-study.

Graduate Programs:
Graduate education in the School of Molecular and Cellular Biology (MCB) is focused at the departmental level: after spending the first semester doing three research rotations, students will formally join both a thesis lab and one of our four degree granting departments. Specific departmental requirements are provided under each department's heading on this Web site. Formal application is made to the School of Molecular and Cellular Biology.

Graduate studies in MCB are offered through the Departments of Biochemistry, Cell and Developmental Biology, Microbiology, and Molecular and Integrative Physiology, along with interdisciplinary programs in the Center for Biophysics and Computational Biology, the Neuroscience Program, and Medical Scholars Program. These provide an exceptionally broad range of training and research opportunities. The Department of Biochemistry at Illinois offers unique opportunities for graduate students to become skilled and creative biochemists and molecular biologists. Outstanding resources in the Department of Biochemistry include internationally recognized faculty, graduate students, and research facilities. The graduate program not only allows research students to learn the latest techniques, but also fosters their development as independent scientists.

The Department of Microbiology is a part of the School of Molecular and Cellular Biology (MCB), which includes the Departments of Biochemistry, Cell and Developmental Biology, and Molecular and Integrative Physiology. The department is part of an umbrella program in MCB that encompasses 80 different research laboratories. Students admitted into any of these departmental graduate programs can select faculty thesis advisors from over 60 active research laboratories in the school. Close ties are also maintained with the School of Integrative Biology, the School of Chemical Sciences, the College of Medicine, and the College of Veterinary Medicine.

The School of Integrative Biology comprises three departments that offer graduate degrees. The departments are animal biology, entomology, and plant biology.

Graduate tuition: $12,993/year in-state; $25,221/year out-of-state. Students accepted into the MCB Ph.D. program receive financial support through fellowships, traineeships, or graduate assistantships, which provide a generous stipend as well as a full tuition and partial fee waiver. Departments guarantee financial support to students as long as they are making satisfactory progress toward the Ph.D. degree. Several fellowships are awarded on a competitive basis to outstanding applicants. Upper-level graduate students are generally supported by research assistantships or interdisciplinary training grants. Students are recommended for training grant funding by their graduate program.

Statistics:
Applied - 28,751
Admitted - 19,434 - 68%
Enrolled total - 7,252
Full Time: - 7,249
Part Time - 3

Standards:
Test - 25th % - 75th %
SAT Reading - 540 - 660
SAT Math - 690 - 780
SAT Writing - 590 - 680
ACT Composite - 26 - 31
ACT English - 26 - 32
ACT Math - 26 - 33
ACT Writing - 8 - 9

Retention / Graduation:
Retention rate - 93%
4-year graduation rate - 65%
6-year graduation rate - 83%

Other Information:
17 Colleges and Instructional units
$583,754,000 Spending on research and development in science and engineering in 2012.
100% of all classrooms have wireless access.
360 buildings on- and off-campus have wireless access.
$29.4 million initiative implementing increased community access to high-speed fiber-optic Internet and developing community-wide Intranet with special federal and state funding.
320 Main campus buildings, 2.8 square miles (1,783 acres).
647 Total buildings, 7.1 square miles (4,552 acres).
32,281 Students from 50 states.
6,914 New freshmen enrolled in fall 2012; roughly 32,000 apply annually.
4,447 International undergraduate students.
5,000+ courses offered; more than 150 programs of study.

Undergraduate Programs and Majors:
Integrative Biology (BS)
Molecular and Cellular Biology (BS)
Biochemistry (BS)

Graduate Programs:
Biochemistry (PhD)
Cell and Developmental Biology (PhD)
Microbiology (PhD)
Molecular and Integrative Physiology (PhD)
Integrative Biology (PhD)

Dual Degree Programs:
MD/PhD
DVM/PhD

Application Deadlines:
Undergraduate: January 2nd
Graduate: Varies based on program

Applications are available online: http://admissions.illinois.edu/apply/app.html

CAMPUS VIDEO:

Basic Information:
UIC is a major research university offering the cultural, business and entertainment opportunities you can only find in a world-class city. As one of the top 200 research-funded institutions in the world, UIC faculty members discover the things that others teach. Choose from 15 academic colleges including the UIC College of Medicine-the largest in the nation-which educates one in six Illinois physicians.

With nearly 2,574 instructional faculty members, there is one faculty member to every 11 students, which allows for a more personal learning experience. What's more, 75 percent of tenured faculty members teach undergraduate courses and 83 percent of full-time instructional faculty members have earned a PhD or equivalent.

16,911 undergrads and 10,669 graduate and professional students make up one of the most diverse student bodies in the United States. Whether living in residence halls, near campus or commuting, there's always something interesting going on, from social events, clubs, sororities and fraternities, to two state-of-the-art fitness centers, and more-not to mention everything Chicago has to offer just minutes away.

Undergraduate Programs:
The College of Engineering at UIC offers an undergraduate degree in bioengineering. The department faculty routinely includes undergraduate students in world-class bioengineering research programs, and maintains strong interactions with faculty in the Colleges of Medicine, Dentistry and Pharmacy, the Department of Biological Sciences, and other engineering disciplines. The undergraduate curriculum includes rigorous training in bioengineering fundamentals, including medical product development, complimented by significant course work in physiology, mathematics and chemistry. Each student must complete a program of required core courses and select an individualized course track in one specialized area (Neural Engineering, Cell and Tissue Engineering, or Bioinformatics) best suited to the student’s interests. The department offers several elective courses to help prepare students for a variety of career paths, including launching start-up companies or careers in industry or consulting.

The UIC Department of BioEngineering has unique resources because of its close affiliation with the clinical and research programs of the University of Illinois Medical Center at Chicago and the opportunities to intern at major biomedical manufacturers (Abbott, Baxter, Biomet, General Electric, and Siemens, for example) in the Chicago and northwest Indiana areas. Students can easily work at facilities on campus or in the adjoining Illinois Technology Park. Senior design projects, co-op assignments, or academic year internships can also be conducted in Chicagoland biomedical industries.

UIC offers a bachelor’s degree in biochemistry. It is a joint program of the Department of Biological Sciences and the Department of Chemistry. It is intended for students planning advanced study in biochemistry or molecular biology, who wish to pursue a medical degree, or who will be seeking employment and careers in biochemistry, molecular biology, biotechnology, or related fields. Students may be advised through either department.

Students can also obtain a bachelor’s of science degree in biology from the College of Liberal Arts and Sciences. The department boasts many talented faculty who teach courses and welcome undergraduates into their labs who are seeking research experience. Many affiliated faculty in colleges outside of LAS also take students into their labs. The Department of Biological Sciences is one of the largest and most active departments at UIC. Undergraduate and graduate training opportunities are offered in all major areas of biology, including molecular, cellular, and developmental biology, neuroscience, ecology, and evolution. The Guaranteed Professional Program Admissions (GPPA) Initiative ensures that qualified undergraduate applicants gain guaranteed postgraduate admission to medical school or other professional programs.

Undergraduate tuition: $9879/year in-state; $22,172/year out-of-state. Financial assistance is available in the form of scholarships, grants, loans, and work-study.

Graduate Programs:
The Graduate Education in the Medical Sciences (GEMS) program is an umbrella program for PhD students, encompassing several departments at the UIC College of Medicine. The GEMS Program offers students integrated training in the biomedical sciences. Graduate programs include the areas of Anatomy, Biochemistry, Biophysics, Cell & Molecular Biology, Genetics, Immunology, Microbiology, Neurosciences, Pathology, Pharmacology and Physiology. Students have the flexibility to choose a mentor from among more than 110 funded research faculty in all departments and PhD programs of the College of Medicine. Areas of research excellence within the broader disciplines include Cancer; Development; Gene Regulation; Host-Pathogen Biology; Lung Biology; Molecular and Integrated Cardiac and Vascular Biology; Proteomics, Genomics & Bioinformatics; Reproductive Biology; Signal Transduction; and Virology.

The Department of Biological Sciences offers graduate degrees in three program areas: Ecology and Evolution; Molecular, Cell, and Developmental Biology; and Neurobiology. Some students also participate in the interdisciplinary doctoral training program in Neuroscience.

The Graduate Program in Neuroscience at the University of Illinois at Chicago (UIC) is designed to provide in-depth training and practical research and teaching experience in fundamental life sciences leading to a Doctor of Philosophy degree in Neuroscience. The Graduate Program is not itself a Department but is an interdepartmental program directly administered by the UIC Graduate College. This interdisciplinary program brings together faculty and students from several UIC Colleges and academic disciplines whose research emphasizes cellular/molecular, systems/cognitive, and behavioral/applied approaches to the study of Neuroscience. Faculty from several Colleges and Departmental Programs participate in the Neuroscience Program. These Colleges include: College of Liberal Arts & Sciences, College of Medicine, College of Dentistry, College of Applied Health Sciences, College of Engineering, College of Nursing, and College of Pharmacy. The faculty also have strong ties to other UIC research centers, including the Laboratory of Integrative Neuroscience. Together, these scientists and clinicians advance our understanding of the brain, provide new treatments, and train the next generation of neuroscientists.

The MS and Ph.D. programs in Bioengineering provide training in the research and development of systems using engineering concepts and methods that apply modern technology to problems of living systems and health care.

Many UIC graduate programs also participate in the prestigious NIH-supported Medical Scientist Training Program (MSTP), a competetive MD/PhD program providing 7 years of support for pursuit of MD and Ph.D degrees in a coordinated seamless experience with the UIC College of Medicine, home of the largest medical school in the country.

Graduate school applicants should have a minimum undergraduate GPA of 3.0. GRE scores, letters of recommendation, and personal statements are also required.

Graduate tuition: $12,059/year in-state; $22,355/year out-of-state. PhD students are eligible for financial assistance in the form of research and teaching assistantships.

Statistics:
Applied 14,564
Admitted 9,151 63%
Enrolled total 3,115
Full Time: 3,097
Part Time 18

Standards:
Test 25th % 75th %
SAT Reading 450 600
SAT Math 500 650
SAT Writing 480 610
ACT Composite 21 26
ACT English 21 27
ACT Math 21 27
ACT Writing 0 0

Retention / Graduation:
Retention rate 79%
4-year graduation rate 24%
6-year graduation rate 54%

Undergraduate Programs and Majors:
Bioengineering (BS)
Biochemistry (BS)
Biology (BS)

Graduate Programs:
Anatomy (PhD)
Biochemistry (PhD)
Biophysics (PhD)
Cell and Molecular Biology (PhD)
Genetics (PhD)
Immunology (PhD)
Microbiology (PhD)
Neurosciences (PhD)
Pathology (PhD)
Pharmacology (PhD)
Physiology (PhD)
Ecology and Evolution (MS/PhD)
Molecular, Cell, and Developmental Biology (MS/PhD)
Neurobiology (MS/PhD)
Bioengineering (MS/PhD)

Dual Degree Programs:
MD/PhD
DDS/PhD
MD/MBA
MD/MPH
Guaranteed Professional Program Admission (GPPA- BS/MD or other professional degree)
BS/MS Bioinformatics

Application Deadlines:
Undergraduate: January 31st
Undergraduates should apply via the Common Application: https://www.commonapp.org/Login
Graduate: January 1st
Application is available online at: http://grad.uic.edu/cms/?pid=1000019

Basic Information:
Purdue University, located in West Lafayette, Indiana, is the flagship university of the six-campus Purdue University system. Purdue was founded on May 6, 1869, as a land-grant university when the Indiana General Assembly, taking advantage of the Morrill Act, accepted a donation of land and money from Lafayette businessman John Purdue to establish a college of science, technology, and agriculture in his name. The first classes were held on September 16, 1874, with six instructors and 39 students. Today, Purdue is a member of the Big Ten Conference, and is a well known world-class research institution. Purdue enrolls the second largest student body of any university in Indiana as well as the fourth largest international student population of any university in the United States.

Purdue offers both undergraduate and graduate programs in over 211 major areas of study, and is well known for its competitive engineering curricula. The university has also been highly influential in America's history of aviation, having established the first college credit offered in flight training, the first four-year bachelor's degree in aviation, and the first university airport (Purdue University Airport). Purdue's aviation technology program remains one of the most competitive aviation-specific programs in the world. In the mid-20th century, Purdue's aviation program expanded to encompass advanced spaceflight technology giving rise to Purdue's nickname, Cradle of Astronauts. Twenty-three Purdue graduates have gone on to become astronauts, including Gus Grissom (one of the original Mercury Seven astronauts), Neil Armstrong (the first person to walk on the moon), and Eugene Cernan (the most recent person to walk on the moon).

Undergraduate Programs:
The Weldon School of Biomedical Engineering offers an undergraduate program in Biomedical Engineering. Training to be a Purdue biomedical engineer requires engineering science, analysis, and design knowledge and skills applied within the context of biological and medical conditions in order to improve human health. Students enjoy the contemporary, state-of-the-art building that houses BME undergraduate classrooms and research laboratories, media rooms, and faculty, staff, and student services offices.

The world has tremendous need for solutions to problems related to the environment, energy, health, food, and sustainability. Biological systems are related to or at the heart of all of these issues. A biological engineer learns to design and analyze biological systems to develop innovative and practical solutions. B.S. graduates are well prepared for careers in the food industry, pharmaceutical industry, biotechnology, and bioprocessing as well as entrance into graduate or medical school. Students may select a major and plan of study within biological engineering that is tailored to their specific career goals. The areas of focus include: Bioprocess engineering and bioenergy engineering; Cellular and biomolecular engineering; Food process engineering; and Pharmaceutical process engineering

The Department of Biological Sciences at Purdue encourages students to get involved in research during their undergraduate career. Undergraduate research is one of the best things a student can do to enrich a Purdue Biology degree. It provides a strong background for classes, a chance to interact with leading researchers every day, and an invaluable understanding of how science happens.

Undergraduate tuition: $8893/year in-state; $27,061/year out-of-state. Financial aid is available in the form of scholarships, grants, loans, and work-study. Students should complete the FAFSA to be eligible for aid.

Graduate Programs:
Biomedical engineering is one of the fastest growing engineering fields, and the knowledge and skills of persons with advanced degrees are in high demand. At the Weldon School, students will find highly interdisciplinary research and teaching that spans contemporary biomedical engineering. The master’s and doctoral-level programs at Purdue University comprise faculty and laboratories from multiple entities, including the Purdue College of Engineering, College of Science, and School of Veterinary Medicine on the West Lafayette campus, as well as the Purdue School of Engineering and Technology and Indiana University School of Medicine on the Indiana University-Purdue University campus in Indianapolis. The combined faculty, staff, and facilities of the two campuses offer unparalleled resources and opportunities for graduate students.

The Purdue University Department of Agricultural and Biological Engineering is consistently ranked among the top in the nation. In fact, the graduate program has been ranked #1 by US News & World Report for the fifth consecutive year. Purdue University has master’s and PhD programs in the following areas of specialization: Agricultural and Biological Engineering; Agricultural Systems Management; Biological Engineering and Technology; Biological and Food Process Engineering; Ecological Sciences and Engineering; and Fluid Power (Engineering).

Graduate study in Biological Sciences at Purdue University is multi-disciplinary, offering a wide variety of choices for doctorate and masters degrees. Major research groups exist in the fields of Development and Disease, Ecology and Evolutionary Biology, and Molecular Biosciences. Areas of research include biology education research; cancer biology; developmental neurobiology; cell biology; ecology and conservation biology; genetics, genomics and computational biology; microbiology; molecular pathogenesis; physiology and behavior; plant biology and bioenergy; structural biology and biophysics. A major advisor may be selected in any of these areas. In addition, several interdisciplinary programs also are available in conjunction with other departments and divisions within the University. We therefore welcome applicants from different disciplines such as chemistry, physics and related fields as well as students from traditional biological backgrounds.

The path to an exciting academic or industrial career in biomedical science begins here with Purdue’s Department of Basic Medical Sciences. The Department of Basic Medical Sciences (BMS) combines the personal attention of a small department, with a unique breadth of training. BMS offers graduate study leading toward a master’s degree and a doctoral degree. The department also offers a combined degree/dual degree option for students in one the of DVM professional curriculum. BMS has active research programs in the following areas: Cancer biology; Muscolo-skeletal biomechanics and skeletal adaptation; Neural development, mechanisms of injury and regeneration; Tissue dynamic spectroscopy; and Cellular and molecular screening and high throughput analysis of cell function.

The Biomedical Sciences Interdisciplinary Graduate Program is aimed at training scientists with an interest in biomedical sciences. This interdisciplinary graduate training program is administered jointly between the School of Veterinary Medicine (SVM) and the Weldon School of Biomedical Engineering. This unique Ph.D. program fills a need for a medically-oriented program for scientists who wish to undertake careers in such areas as implantable medical devices, natural biomaterials, tissue engineered therapies, drug delivery strategies, and diagnostic sensors. This program emphasizes biomedical approaches to diagnose and treat human diseases. Two signature areas of this program are biomedical research in spinal cord injury and nanomedicine approaches to cancer and other diseases. Applicants should have at least a bachelor’s degree. The minimum requirements for GRE (preferably higher since this program is very competitive) are verbal: 550; and quantitative: 700. Applicants whose native language is not English must achieve a TOEFL score of at least 550 (paper version) or 213 (computer version) or writing-18, speaking-18, listening-14, reading-19, total-77 (Internet version). Interest in the IBSC Ph.D. track by students with backgrounds in fields such as biology, biochemistry, chemistry, biophysics, physics, computer science, and pharmaceutical sciences is anticipated and encouraged. Students interested in biomedical engineering who have undergraduate or graduate degrees in engineering should apply directly to the Biomedical Engineering Graduate Program in the Weldon School of Biomedical Engineering.

Graduate tuition: $8893/year in-state; $27,061/year out-of-state. Financial aid is available to PhD students in the form of research and teaching assistantships.

Statistics:
Applied - 29,721
Admitted - 20,318 68%
Enrolled total - 6,821
Full Time: - 6,773
Part Time - 48

Standards:
Test - 25th % - 75th %
SAT Reading - 490 - 610
SAT Math - 550 - 690
SAT Writing - 500 - 610
ACT Composite - 24 - 30
ACT English - 23 - 30
ACT Math - 24 - 31
ACT Writing - 0 - 0

Retention / Graduation:
Retention rate - 90%
4-year graduation rate - 38%
6-year graduation rate - 70%

Other Information:
Princeton Review Best Value University
Top Ten Education Technology Innovators, according to Campus Technology Magazine
14:1 Student:Teacher ratio
1st University to place a band member on the moon (Neil Armstrong)

Undergraduate Programs and Majors:
Biomedical Engineering (BS)
Biological Engineering (BS)

Graduate Programs:
Biomedical Engineering (MSE/MS/PhD)
Biological Engineering (MS/PhD)
Basic Medical Sciences
Biomedical Sciences Interdisciplinary Graduate Program (PhD)

Dual Degree Programs:
Fifth-Year Combined BS/MS in Biomedical Engineering (with Thesis)

Application Deadlines:
Undergraduate: November 1st Early Action and select programs; February 1st, Regular Admission
Students should apply using the Common Application: https://www.commonapp.org/Login
Graduate: Varies by department

Hospira is a global US based pharmaceutical company that has its headquarters in Lake Forest, Illinois. The firm is also involved in manufacturing medical devices and is driven by the mission of “advancing wellness”. It has about 15,000 employees and is considered as the world’s largest manufacturer of generic injectable pharmaceuticals.
Long back, Hospira was a division of Abbott Laboratories and later on it moved out to function as an independent company. The products developed by this firm are used by the hospitals, home – care health providers, long term care facilities and clinics. Hospira is a member of NYSE and is traded as HSP.

Popular biotech products
As already stated, Hospira is the largest producer of pharmaceuticals and medical devices. This explains that the list of products for both medical devices and pharmaceutical products would be endless. The following list will speak of some of the most popular and important products developed by this firm.
• Azithromycin
• Biosimilars
• Bupivacaine
• Cefazolin
• Claforan
• Clindamycin
• Dobutamine
• Erythropoietin
• Filgrastim
• Gentamicin
• Heparin
• Irinotecan
• Morphine
• Ondasetron
• Precedex
• Propofol
• Topotecan
• Vancomycin
• Zantac

The firm also produces medical devices for hospital and other similar health care centers. These are:
• Gemstar Sp
• Hospira Mednet software
• Lifecare PCA
• LIfeshield
• Plum A+
• Symbiq – an infusion system
• TheraDoc

Latest discoveries
Hospira is constantly at par with the latest innovations and developments taking place in the medical field. It is also involved in various development programs and produces latest products that are of benefit for the world at large.

Inflectra – is the first biosimilar monoclonal antibody developed by this firm to have received approval in Europe. This drug is indicated for treatment of rheumatoid arthritis, plaque psoriasis and inflammatory bowel disorders.

Recent company takeovers
Hospira was earlier a division of Abbott Laboratories and later on in the year 2004 it took off to be an independent firm. The firm recognizes the importance of collaborations and partnerships with various firms for expanding their business and research areas. The following is a list of collaborations that have taken place recently:

Collaborations
• In the year 2007, the firm purchased Mayne Pharma Ltd., for $2.1 billion. Mayne is an Australian based firm and specializes in injectables. This collaboration widened Hospira’s international reach and also extended its research into the field of oncology.
• In the year 2009, Hospira collaborated with an Indian pharmaceutical firm named Pliva – Croatia. This collaboration was worth $400 million and widened the parent company’s reach in generic injectable pharmaceuticals. In the same year, the firm also joined hands with TheraDoc which is a clinical informatics company.
• The next year, 2010 also witnessed the partnership of Hospira with Javelin pharmaceuticals at $145 million.

Recent corporate news
The worldwide sales of Hospira in the year 2011 was recorded to be $ 4.1 billion.

Work culture
The work culture at Hospira is very positive and at the same time dynamic. It considers its employees as its assets and hands out monetary benefits and awards to them for their exemplary performance. The firm has several programs and health and medical benefits for its employees. These consist of Health Reimbursement Account (HRA), Health Savings Account (HAS), generously matched 401 (K) retirement savings plan, and plans for supporting the development and education programs.

Interesting events
Hospira with its constant efforts to carry out top quality research for developing world class pharmaceutical products and medical devices is always in the news. The current year has several upcoming interesting events. These are as follows:
• The firm will present at the Morgan Stanley Global Health Conference
• Hospira announces the first and second quarter financial results.
• The firm obtained exclusivity for one its products named Precedex meant for pediatrics.
• In the current year, the firm signed an International Distribution Agreement with Q Core for sapphire Infusion System.
• Hospira would also present its results and findings in upcoming conferences.
• Earlier in this year, the firm’s TheraDoc Infection Control Assistant was ranked number 1 in the KLAS report.

Recent job openings
Hospira is forever on the hunt for young and experienced individuals to join them in their research and develop new innovative products for the world at large. Following is a list of job openings available with this firm:
• Manager, Regulatory affairs, Medical Device: The individual is responsible for implementing the strategies and listing down the priorities. He should also be competent enough to analyze the risks as well as the benefits in developing strategies for manufacturing medical devices. For applying for this position, the individual should hold at least a bachelors degree in life science, but a master degree holder will be given preference.
• Director, Program management: The individual will be responsible for ensuring on time delivery of the multiple programs for development of new products and would also be accountable for architecting of the products. For applying for this job opening, the individual should have more than 10 years of experience in industry and should also have strong leadership skills.
• Director, Global safety Operations: In this, the individual will have to lead a team of analysts and is responsible for the quality as well as on time delivery of the devices for FDA regulatory reports. Candidates applying for this job should have a bachelor’s degree in health or technical field. The individual should also have a minimum of 5 years of experience in health care environment and should also possess knowledge of FDA regulated business.
• Senior manager, Global inspections: In this the individual will have to directly work at the manufacturing sites to inspect the entire manufacturing process of the products. He would also be responsible for development and implementation of global strategies and global model for an effective internal audit program. Candidates who wish to apply for this position should have a minimum of 7 – 10 years of industrial experience and should posses’ strong influential skills to convince the stakeholders.
• Principal engineer: In this the individual will function as an important team member in the R&D department. The candidates should have 10 – 15 years of experience in Engineering or should also have 4 – 8 years in MS.

Shire UK is a biopharmaceutical firm founded in 1986 that develops pharmaceutical drugs by working in close conjugation with nurses, doctors, health professionals and pharmacists. The firm develops pharmaceutical products for various life threatening diseases such as Alzheimer’s disease, ADHD – Attention deficit Hyperactivity Disorder, fabry disease, ulcerative colitis, constipation, essential thrombocythaemia, Hunter syndrome, chronic kidney disorder, Gaucher’s disease and heredity angioedema. Shire UK functions with the mission of developing drugs that would help individuals lead a healthy life.
The firm’s product is marketed in about 50 countries and it has offices across 29 countries globally with employee strength of more than 5,300.
Popular biotech products

Shire UK produces and develops pharmaceutical products for the following disease areas:
• Neuroscience
• Rare diseases
• Gastrointestinal disorders
• Regenerative medicine and
• Internal medicines

It develops products with the view that they can help patients with life threatening disease conditions lead better and comfortable lives. The following is a list of products that has been developed by this firm:
• Adderall XR
• Agrylin
• Alertec
• Calcichew
• Carbatrol
• Dermagraft
• Elaprase
• Elvanse
• Equasym XL
• Estrace
• Exputex
• Firazyr
• Fosrenol
• Foznol
• Intuniv
• Lialda
• Mezavant
• Mezavant XL
• Midon
• Mintec
• Pentasa
• Proamatine
• Reminyl
• Replagal
• Resolor
• Vpriv
• Vyvanse
• Xagrid

Latest discoveries
The product pipeline of Shire pharmaceuticals is loaded with several new and innovative products to combat various disease conditions. Of the several products that have been listed below many are in the phase 3 of clinical trials and the rest are in the phase 2. Below is the list:
• SPD 555 for chronic constipation
• SPD 557 for gastroesophageal reflux
• ABH 001 for epidermolysis bullosa
• SRM 003 for acute vascular repair
• SPD 606 for dry eye disease
• SPD 602 for chronic iron over load
• HGT – ROP – 001 for retinopathy prematurity

Recent company takeovers
Shire UK recognizes the importance of collaborations and partnerships that would widen the research areas and also help expand the business prospects. The following list speaks of some of the recent acquisitions in the year 2013 by this firm:
• The firm acquired Sarcode, a biopharmaceutical firm based in California. This collaboration strengthened Shires’s research in the ophthalmologic area.
• Shire joined hands with Premacure AB in the current year. This collaboration caused the development of a protein replacement therapy that is used for prevention of premature retinopathy.
• Early in this year, Shire acquired Lotus tissue repair. This collaboration lead to the development of protein replacement therapy for treatment of epidermolysis bullosa.
• The firm also acquired Ethris GmbH and both the companies announced a research based alliance for development of novel – RNS based therapeutics. This can be used for treatment of several monogenic genetic diseases.

Work culture
Brave - is the word to define the work culture at Shire which has a dynamic environment. The firm is mission driven and believes in creating products that would help individuals with deadly diseases to lead better lives. The firm has operations worldwide and is ever ready to hire aspirant individuals who are willing to take the company to greater heights.
The working environment of this firm is truly positive that gives each employee his own space to research, experiment and grow. The employees at Shire enjoy number of benefits; some of which includes health insurance, flexible spending accounts, disability benefits, paid time off, employee assistance program, healthy lifestyle reimbursement, educational assistance, employee stock purchase plan, employee referral incentives, adoption assistance and the 401 (K) plan.

Interesting events
The firm is always in the public eye due its constant innovations and developments in the field of pharmacy. The year 2013 has indeed been an eventful year for this firm and the following list will prove the above mentioned fact.
• Shire will present at the Morgan Stanley Global Health Conference and the Bank of America Merrill Lynch Global Health Conference.
• In the mid of this year, the firm announced the launch of educational resource materials for individuals with diabetes.
• The firm also announced scholarship awards for individuals with ADHD.
• The drug named Vyanse got approval in the US for treatment of children and adolescents with ADHD.
• Earlier this year, the firm received approval in UK for yet another drug– Elvanse for treatment of children and adolescents with ADHD.

Recent job openings
The following is a list of job openings at Shire pharmaceuticals.
• Director, Pharmacovigilance and Risk management – id: 6348BR: In this, the individual will have the primary responsibility of managing the therapeutic division. The candidates need to have a post graduate degree and past experience in the relevant field.
• Controlled substance manager – id: 6360BR: The individual is responsible for managing the manufacturing, packaging, distribution and a warehouse site of the firm’s outsourcing business areas. The candidates should have past experience in handling DEA audits and inspections. Candidates interested in applying for this position should hold a graduate degree with past experience in relevant field.
• Associate Director, Controlled Substance Management – id: 6362BR: The individual will work directly with the outsourcing department of this firm. He is also responsible for providing appropriate support for conducting data analysis.
• Associate director, Risk management – id: 6350BR: In this, the individual will be responsible for reporting directly to the senior director of risk management. His responsibilities will include coordination, contribution and facilitation of plans related to risk management. The candidate should have past experience in pharmacy field and should be a graduate at the minimum.
• Director Compliance – id: 6154BR: In this, the individual will have to assist the vice president of compliance. This is an altogether newly created position in this firm and interested candidates should preferably be a law graduate with experience in implementation in commercial compliance programs.
• Director, Medical writing – id: 6065BR: The individual will be responsible for medical writing of the business projects. He would also be accountable for creating the marketing objectives of business proposals. The candidate should hold a doctorate degree in the relevant field.
• Senior Sales Analytics and reporting analyst – id: 6171BR: The individual will be responsible for the development and support of Veeva CRM solutions. The candidates should hold a graduate or equivalent degree in relevant field and should have experience in pharmaceutical industry.

Hi guys, I know that Protein structure related to their function. Certain protein usually have alpha helix is more prominent but certain protein have beta structure more prominent. My question is which aminoacid is favourable to form alpha helix and beta structure? What function unique to alpha helix and beta structure?

LFB Group is a biopharmaceutical company based in France and directed towards development of therapeutic proteins. It is the 5th largest company worldwide in the field of plasma – derived medicinal products. The firm develops and manufactures products for treatment of serious and rare disorders. The treatment of diseases is the main motto of this firm and it leaves no stones unturned for fulfilling this mission. LFB Group also specializes in development of biological medicinal products that also aids in treatment of rare disorders.

Popular biotech products
LFB Group develops products for various life threatening diseases. Its area of expertise includes those of immunology, intensive care and haemostasis. The following is a list of drugs marketed by this firm:
• Aclotin
• Alfalastin
• Arganova
• Betafact
• Clairyg
• Clottafact
• Factane
• Gammatetanos
• Hemoleven
• Human hepatitis B immunoglobulin LFB
• Ivhebex
• Kanokad
• Protexel
• Tegeline
• Vialebex
• Wilfactin
• Wilstart
• Ydralbum

Latest discoveries
LFB Group is constantly coming up with latest discoveries for treating severe disease conditions. The firm’s latest discovery is in the field of pneumology where it develops replacement therapy products for treatment of α – 1 antitrypsin deficiency that is known to cause pulmonary emphysema in adults.
Recent company takeovers
LFB Group recognizes as well as understands the importance of collaborations with other firms. In the year 2007, the firm took over MAbgene at €6m. MAbgene is involved in the production of antibodies and glycoproteins in cell based animal systems.
The firm later in the year also joined hands with GTC Biotherapeutics for expanding its research area on transgenics.

Recent corporate news
LFB Group also has its business spread overseas and over the past few years has witnessed a 60% rise in the international turnover. However, the year 2011 was a bit difficult for this firm and it made a comeback in the next year where its total turnover increased by 7.7%.

Work culture
The work culture at LFB Group is dynamic and at the same time very positive. The firm considers its employees as its assets and rewards them handsomely for their hard work and perseverance. The employees of this firm also work very hard to achieve the desired goals and carry out quality research to churn out the best therapeutic products for the treatment of unusual disorders.

Interesting events
LFB Group has forever been in the limelight due to its constant efforts to develop medicinal products for treatment of various disease conditions. The firm has also received several awards and recognition for its exemplary performance. Some of the interesting events for this firm have been listed below:
• The firm was awarded The Galien Award in the rare disease category in the year 2011. This award was given for the firm’s innovation in the field of human fibrinogen. In the same year, Thallion and LFB completed the patient enrollment for carrying out the Phase II Shiagatec trial.
• In the year 2010, the firm began the procedure for acquiring Austrian Plasma Collection Group.
• In the year 2011, the firm announced patenting of monoclonal antibodies that have enhanced activity in the US.
• In the year 2012, the firm bagged the Jacques Oudin Prize for clinical and basic immunology.
• In the current year the firm signed a licensing agreement with Shin Poong.
• In the year 2012, the firm along with TG therapeutics completed the licensing agreement for development of Ublituximab.

Recent job openings
Currently there are 8 job openings available with LFB Group. Interested candidates can note down the reference id and can leave an online application along with their resume. If selected, they would be contacted by the recruiters. The following is a list of job openings:
• Officer (e) recruitment – CDD 6 months – id: CR/0913/EC: This post is available for individuals who wish to be a part of the HR team of this firm. The selected candidate will be responsible to manage the tasks from scratch to finish. Candidates need to have a minimum of 2 -3 years of experience in recruitment process and should hold a higher degree of education in engineering, psychology or third cycle in HR.
• Charge of Drugs – id: CR/0913/EC: In this, the individual will be responsible for monitoring the safety of medicines in the developing countries and also take charge of the marketing process that need to be done following the standard European guidelines. The candidates need to have at least 3 years of experience in pharmacovigilance and should either be a pharmacist or hold a doctorate degree in relevant field.
• Production Technician – id: DB/13-07/TP: The individual is responsible for carrying out the production, fractionation and purification of raw materials. He would also be responsible for working in accordance with the procedures and should also be able to deliver the products in said time. Candidates having past experience in similar kind of job will be given preference.
• Pharmacist assistance release pharmaceutical – id: PALP/0813/EC: In this, the individual’s role will revolve around three areas namely: checking, evaluation and assisting the head of pharmaceutical release. The candidates need to have a minimum of 1 – 2 years of experience in quality control and should be a graduate in pharmacy.
• Trainer material, equipment and local – id: PALP/0813/EC: The individual selected for this job position is entitled to provide the raw materials, as well as the materials to be used in the local production. The work should be carried out based on the guidelines of GMP and hygiene and safety. The candidate should be able to carry heavy loads and should have experience in the relevant field.
• Quality control manager – id: RCQ/0513/FdL: In this, the individual is responsible for establishing criteria for analytical acceptances. The candidate should have at least 3 years of experience in validation methods and should be a doctorate either in pharmacy or sciences.
• Manager platform Galenics –id: RPG/0513/FdL: Individual will be responsible for exploring new technologies. He should have 3 – 5 years of experience in project management.
• Head of laboratory development of liquid and lyophilized forms – id: RLG/0313/FdL: The individual will be responsible for addressing issues related to development of liquid and lyophilized forms. Should have 5 years of experience in relevant field.

MorphoSys AG is a German biotechnological firm directed towards research and development of antibodies. The firm is involved in developing human antibodies containing 100% proteins.
This company was the developer of HuCal, which is the first antibody library technology in the field of pharmaceuticals. It develops antibodies for the treatment of various diseases such as Alzheimer’s disease, rheumatoid arthritis, cancer, and many more.

Popular biotech products
The firm has developed about 80 biotech products; of which 20 are in the clinical trial phase. Of these products, the firm’s most important and effective program is the MOR 103 which is indicated for treatment of rheumatoid arthritis and multiple sclerosis. This program was developed in collaboration with GlaxoSmithKline.

Latest discoveries
MorphoSys AG is constantly striving to develop therapeutic products that will be of benefit to patients living with various disease conditions. Of late, the firm has several products in the pipeline that are yet to hit the market. These drugs have been listed below:
• Ganterenumab
• MOR208
• Gusselkumab
• BHQ880
• LFG316
• OMP-59R5
• MOR202
• BAY 94-9343
• CNTO 3157
• Vantictumab
• LJM716
All of the above mentioned products have completed the phase I of clinical trials and are now either in the second or the third phase of trials.

Recent company takeovers
MorphoSys AG recognizes and understands the importance of collaborations and partnerships with other firms. This firm has developed several products in partnership with several other biopharmaceutical firms. It has rich reputation of positive alliances with other firms. The following list speaks of the alliances of this firm:
• The firm collaborated with Astellas Pharma in the year 2007. The next year, Atellas Pharma decided to extend the agreement for 4 more years.
• The firm joined hands with Bayer health care and the partnership lead to the development of BAY 94-9343 for treatment of cancers.
• It also partnered with Contrafect in 2011, Boehringer Ingelheim in 2010, Daiichi Sankyo in 2006 and Kaneka in 2007.
• MorphoSys AB also entered into alliance with Heptares in the year 2013 and both the firms have signed an agreement for discovering a novel antibody therapeutic targeting GPCRs.
• The alliance with Jassen Biotech witnessed the development of 2 products that are in the clinical trial stage.
• The firm signed a 5 year license agreement with Merk & Co. to use the parent firm’s HuCAL GOLD and AutoCAL technologies.
• In the year 2004, the firm joined hands with Novartis and developed multiple active therapeutic antibody programs.
• The firm also entered into collaboration with Oncomed pharmaceuticals and developed OMP-18R5 for treatment of cancers.
• MorphoSys also collaborated with Pfizer, PronChon Biotech and Roche. These collaborations witnessed the development of drugs that will be used for treatment of diseases like rheumatoid arthritis, Alzheimer’s disease and cancer.

Recent corporate news
The stock price as of December 2012 was € 29.30 and the total number of shares issued are 23, 358, 228.

Work culture
The work culture at MorphoSys is very positive and at the same time vibrant. The company has 3 core values – honesty, trust and respect. The employees of this firm are given enough opportunity to gain experience and grow and develop world class antibody therapeutics. The work environment at this firm is attractive and of international standards with committed and hardworking employees who leave no stone unturned for churning out the best drugs.

MorphoSys AB also has several benefits for its employees which includes incentives, bonuses for exemplary performance and flexible working hours. The firm also has a Biokids day care center for mothers who wish to come to work but cannot with their small kids. They can leave their kids at day care center and concentrate on their work

Interesting events
MorphoSys AG takes part in several interesting events of its interest and also is always in the news due to its development of novel antibody therapeutic technologies. The current year has indeed been an eventful year for this firm. The following list speaks of some of the interesting events to have taken place in 2013.
• The firm participated in the Bank of America Merrill Lynch Global Health Conference and Berenberg Bank and Goldman Sachs Second German Corporate Conference.
• The firm published its 9 months report in the month of July.
• In the month of August, the firm closed its collaboration with Celgene and increased its financial guidance.
• In addition, MorphoSys and Celgene join hands again to advance the CD 38 cancer program MOR202 for patients suffering from multiple myeloma.

Recent job openings
The firm is forever on the hunt for new and dynamic individuals with analytical minds who can take the firm to newer heights. The following is a list of job openings with this firm:
• Assistant to the Chief Development Officer: In this, the individual is responsible for handling all the tasks for smooth functioning of the back office as well as help the chief development officer to fully concentrate on his or her tasks. Interested candidates need to hold a graduation degree in pharma with a minimum of 5 – 8 years of experience at executive level. The individual should also be able to handle the assigned tasks single handedly.
• Legal counsel: In this type of job, the individual would have to handle all legal matters of the firm with special mention of law issues related to equity and capital market. The individual will also have the responsibility of supporting and working in close collaboration with the legal team. Interested candidates who wish to apply for this position should have completed 2 state examinations and in addition should possess high level of commitment and be proactive.
• Werk Student in Teilzeit: This is a part time post applicable for students who wish to gain some industry experience along with studies. The individual will be responsible for supporting the HR team and should be able to handle administrative tasks. The candidate should be a quick learner and should be able to work for at least 20 hours in a week. Candidates who are willing to stay on for a period of 6 months should apply and the firm seeks individuals who are interested in long term cooperation.

Elan, a drug based firm was founded in the year 1969 in Ireland. The firm develops products for individuals suffering from life threatening diseases. It works very hard to produce innovative therapies and makes sure that it reaches the population with unmet medical needs. The firm is also conducting research trials in the area of auto immune diseases such as rheumatoid arthritis, multiple sclerosis and inflammatory bowel diseases. The firm is also extending its research to produce drugs that would ease and treat physiological and neuropathic pain.

Elan started off as a private ltd. company and went on to become a public ltd company in the year 1984.

Popular biotech products
Elan is dedicated to produce and develop drugs for treating diseases like Alzheimer’s and bipolar disorders. The products developed for treating this disease condition is ELND005 which is basically a β amyloid anti – aggregation agent. The effectiveness of this molecule was studied in patients with Alzheimer’s and bipolar disorder I and its efficacy proved. The drug was also tested on patients with Down syndrome.
It has been recommended that individuals with Alzheimer’s disease should take drug in dosage of 250mg daily twice.

Tysabri is a drug that is marketed by two firms. Earlier it was named as antregan which is indicated in conditions of multiple sclerosis and Crohn’s disease.

Latest discoveries
Amongst the various discoveries, the firm has made several notable contributions in the field of neurology for treating patients with neurological disorders. Of the several discoveries, of late the firm is working to develop a vaccine called ACC-001 for Alzheimer’s disease. It has also developed AAB-003 monoclonal antibody as a part of Alzheimer’s immunotherapy program.

Elan Corporation is also conducting extensive research to study the Parkinson’s disease. It is in the process of developing therapeutic drugs for this disease. The firm together with Wyeth is conducting Phase III clinical trials for the drug bapineuzumab.

Recent company takeovers
Elan Corporation understands and recognizes the importance of collaborations and affiliations with several firms. Partnerships not only help in widening the business prospects but also helps in conducting quality research.

In the year 2013, the firm decided to give away the right to sell the drug Tysabri to Biogen Idec. The deal was worth about $ 3.25 billion.
Elan has also joined hands with Wyath for conducting the phase III clinical trials for bapineuzumab. However, the results for this drug for the previous two phases were non – conclusive, but Elan is hopeful that this drug can be effective for treatment of Alzheimer’s disease.

Recent corporate news
Elan Corporation is traded in the shares of New York as well as Irish stock exchanges. The firm holds about 49.9% equity interest in Janssen Alzheimer Immunotherapy and will also receive 49.9% share of profits. The firm is also entitled to receive royalty payments for commercialization of AIP products.
Elan also receives royalty on in – market sales of the drug Tysabri. In the year 2010, the firm was fined $203m for marketing of epilepsy drugs.

Work culture
The work culture at Elan Corporation is very dynamic and positive. The people of Elan believe in science and work with the faith, that with their knowledge and hard work they can certainly make a difference in the lives of patients living with several disease conditions.
Elan is forever on the lookout for individuals who are vibrant and full of energy. Individuals who are ready to undertake any challenges for creating a better and disease free living world. The working environment of this firm is very unique and offers its employees an opportunity to grow and achieve the impossible.

The firm is a good paymaster and also rewards its employees for their outstanding performance. Not just this, the firm also has special provisions for its employees such as life insurance, health insurance that covers both dental and vision related issues, disability benefits, assistance for educational purposes, flexible spending accounts, annual paid time off, employee stock purchase plan, referral incentives and retirement plans.

Interesting events
Elan Corporation with its constant development and innovations is constantly in the news. The current year has indeed been an eventful year for this firm. Following is a list of interesting events that have taken place.
• In the month of September, the firm announced the initiation of dosing of Scyllo inositol in patients with Down syndrome.
• The firm reported the second quarter of financial results.
• The firm was awarded injunction against the Royalty Pharma.
• The firm entered into a partnership with Theravance Royalty participation agreement worth $ 1 billion.
• The firm also provided update on the drug Tysabri transaction and $1 bn shares.
• Earlier in this month, the firm along with Biogen Idec submitted applications for use of Tysabri in Anti – JCV antibody negative patients with multiple sclerosis.
In addition to these, the firm also took active participation in the following events:
• Elan Perrigo Joint Conference Call.
• Q2 2013 Elan Corporation, PLC earnings conference call

Recent Openings:
At present there are no recent openings.

Spectrum pharmaceuticals is a biopharmaceutical firm based in California. It is directed towards developing therapies for cancer patients. The firm’s area of expertise includes oncology and hematology. People of spectrum pharmaceuticals are mission driven – they are committed towards building better treatment options for individuals suffering from cancer.
The firm is a member of NASDAQ and is traded as SPPI.

Popular biotech products
Spectrum pharmaceuticals is always carrying out worthy and quality research to develop innovative products for oncology and hematology. Till date it has developed several products and following is the list which includes some of them.
• Apaziquone
• Belinostat
• Ozarelix
• Captisol – enabled melphalan
• SPI – 1620
• MTRN – 2696
• Ortataxel
• Renazorb
• SPI – 2012
• Lucanthone
• SPI – 205

The above mentioned drugs are basically meant for treating diseases like cancer. These drugs have the potential of showing effect for even late – stage cancers. These drugs have unique formulations and show effect even for seriously ill patients.

Latest discoveries
Spectrum pharmaceuticals is always carrying out research to develop drugs that can be beneficial to cancer patients. Of late, the firm has developed several drugs as well as injections for cancer patients. Following is the list of latest discoveries by this firm:
• VinCRIstine sulphate LIPOSOME injection
• Ibritumomab Tiuxetan
• Pralatrexate
• Apaziquone
• Menadione topical lotion
• Renazorb
• Topotecan liposome injection
• Vinorelbine liopsomes injection
All these drugs have a unique formula that works against specific types of cancers. The drugs have completed the Phase II of clinical trials and are about to step into the last phase.

Recent company takeovers
The firm recognizes the importance of partnering with several other firms and organizations not just for building the business but for also development of world class drugs that would be of benefit to the cancer patients who are in their last stage of the disease. The firm has joined hands with several biopharmaceutical firms in order to strengthen the drug development process and assess the risk associated with the development process.

Spectrum pharmaceuticals has collaborated with Allergan, Biogen Idec, Bristol – Myers Squibb, Hansdok, Topotarget and Nippon Kayaku. The firm joined hands with Hanmi pharmaceutical company for development and commercialization of the drug SPI-2012. The firm also entered into collaboration with Bayer for acquisition of the licensing rights to market Zevalin.

Recent corporate news
The latest NASDAQ share price was $ 7.91.

Work culture
The work culture at Spectrum pharmaceuticals is vibrant and at the same time dynamic. The firm is committed to excellence and values integrity, quality work, patient focus, and people. The company has the spirit and the will to accomplish the most difficult of tasks.

Spectrum pharmaceutical values its employees and is a firm believer that its employees are its assets. The work environment in this firm is pretty challenging and the employees are given their own space to experiment and come out with good results. Individuals can learn and grow old with this company and with their research skills and analytical mind can take the firm to greater avenues.

The firm also has several benefits for its employees such as medical plans, paid long term disability, deeply discounted voluntary life, stock options, 401 (K) plans and spectrum employee stock exchange plan.

Interesting events
Spectrum pharmaceutical with its research and ongoing work in developing drugs for cancer patients is always in the public domain. The current year has indeed been an eventful year for this firm. The following events will confirm the above mentioned statement:
• The firm acquired Talon therapeutics in the month of July, 2013.
• The firm would also present at the Morgan Stanley Global Health Conference.
• In the year 2005 and 2009, it was voted as one of the best companies to work with.
• Spectrum pharmaceuticals has been ranked as one of the fastest growing companies of North America.

Recent job openings
The firm is forever on the hunt of young and experienced individuals to join their firm and develop world class therapies for the treatment of cancer. The following is a list of current job openings for the firm:
• CRA Manager – id 196-470: The individual will have to perform line management responsibilities for all CRAs as well as coordinate their activities. Candidates who wish to apply for this position need to have at least 7 years of experience in clinical research and should be a graduate in science, medical or any other relevant field.
• Marketing Manager, Brand Management – id: 195-470: For this position, the individual would be responsible for expanding the brand responsibilities of Fusilev and 2 other products that are in the pipeline. He also has to coordinate with the other members in his team and serve as a mentor and role model. Interested candidates should have a bachelor’s degree; however MBA degree will always be given preference. They should also have a minimum of 6 years of experience in healthcare industry with 3 years of specialized experience in oncology.
• Senior Clinical Research Associate – id 192-470: The individual will have to assist in the stage of designing, planning as well as implementation of clinical trials. He would also be responsible of managing and conducting pre study and initiation of closeout visits. The candidates should be BA, BSN or BS and should have a minimum of 5 years of experience as Sr. CRA or should at least have 3 years of CRA related experience.
• Oncology Account Manager – id: 190-470: In this, the individual will be responsible for the achievement of the goals and market share targets in their territory. He should have strong communication skills and should be able to communicate effectively about the product information and disease condition to the customers. Interested candidates should have a bachelor’s degree with minimum of 5 years of experience in pharmaceutical sales.
• Associate director of Managed Markets – id: 173-470: In this, the individual will be responsible for directing as well as marketing for all activities related to the management field. The candidate should be a graduate with minimum of 10 years of experience in biotech or pharmaceutical sales. He should also have 3 years of experience in marketing oncology related therapeutic drugs.

AMAG pharmaceutical is a pharmaceutical firm that works towards developing products for treating various chronic kidney conditions. The firm also produces pharmaceutical products in the iron group category for patients suffering from anemia. It also supports many medical programs for the sake of improving the health of one and all.

Popular biotech products
AMAG pharmaceuticals develop and markets iron products. As of now, the firm has two products in the market: Feraheme which is intended for intravenous use and MuGurad which is an oral wound rinse.

Feraheme is indicated for use in patients with iron deficiency anemia. It is particularly used in patients with chronic kidney disease. It needs special mention here that, this product should not be given to patients who exhibit intolerance towards it or have known hypersensitivity to this drug.
MuGuard is a mucoadhesive oral wound rinse that is indicated for treatment of mucositis caused due to side effects of radiotherapy or chemotherapy. This oral wound rinse can also be used for treatment of other types of oral wounds such as mouth sores and injuries which includes canker sores, traumatic ulcers and aphthous ulcers.

Latest discoveries
AMAG pharmaceutical develops iron containing products for treatment of anemia in patients suffering from chronic kidney disease. Of late, in the year 2010, the firm launched MuGuard which is an oral wound rinse meant for treating oral wounds and several types of mouth ulcers. This product was released in the market when it received 510 (K) clearances from the US Food and Drug Administration. The firm received the US commercial rights for MuGuard in the year 2013.

Recent company takeovers
The firm recognizes as well as understands the importance of collaborations and partnering with other firms. Collaborations increase the chances of widening the areas of research which helps both the parties expand their business prospects. The following is a list which provides details about the collaborations and acquisitions by AMAG pharmaceuticals.
• In the year 2010, the firm joined hands with Takeda for development and commercialization of Feraheme in 5 regions namely Canada, Turkey, Europe, Asia pacific countries and the Commonwealth of Independent States.
• In 2008, the firmed entered into collaboration with 3SBio Inc. to commercialize Feraheme in states of China.

Recent corporate news
AMAG pharmaceuticals is a member of NASDAQ and is traded as AMAG. The stock quote for this firm is 25.07 and the volume stands as 47,833.

Work culture
The work culture at AMAG pharmaceuticals is very dynamic and at the same time vibrant. The firm regards its employees as its assets and rewards them handsomely for their exemplary performance. In addition, the firm also provides several benefits to its employees.
The following are the benefits offered by this firm to its employees:
• Medical insurance
• Disability
• Flexible spending accounts that covers the heath and dependent care
• Life / accidental death
• Supplemental life insurance
• 401 (K) plan
• Time off
• Tuition assistance
• Credit union
• Employee assistance program
• Adoption leave

Interesting events
The firm is constantly on the move and is carrying out research to develop products that would help in treatment of diseases. The following is a list of events for the current year showcasing the skills and achievements of AMAG pharmaceuticals.
• The firm would present at the upcoming investor conferences
• The firm announced the issuance of new US patent for Ferumoxytol.
• It also announced the second quarter and six month financial results for the current month.
• The firm launched a program known as “Iron matters” for educating the patients about iron deficiency anemia.
• AMAG pharmaceuticals also supports the medical community through the AMAG Medical Institute.

Recent job openings
The firm is forever on the hunt for young and experienced individuals who with their hard work and perseverance can take the firm to new defined avenues and produce world class products for the world at large. The firm is an equal opportunity employer and sees no bar in religion, caste, color, race, sexuality, physical or mental disability, marital status, veteran status and creed. The following is a list of job openings at AMAG pharmaceuticals:
• Senior Medical Science Liasion – id: 520: In this, the individual serves as the main person for handling the field – based scientific resource pertaining to healthcare providers, patients, colleagues of the firm and industry partners. The individual will also be responsible for building professional relationships with KOL for widening the areas of research and business prospects. The candidate should have advanced clinical scientific degrees with minimum of 3 – years of experience in MSL pharmaceutical.
• Regional access manager – id: 531: This is a newly created job position of this firm. The concerned individual would have a major role to play in supporting the business and will have to report to the National Director of Account Management Team. At the minimum the candidate should be BA or BS with at least 7 – 10 years of experience in the relevant field.
• Special Account Representative – id: 543: The individual will be responsible to build strategic account relationships and should possess strong analytical skills. He should have BA or BS degree with more than 4 years of experience in pharmaceutical sales.
• Executive Assistant – id: 556: In this, the individual will be responsible to provide administrative support in legal affairs. He should be a graduate and should have more than 5 years of experience in administrative role of similar kind.
• QA Manager – id: 557: The individual will be responsible to facilitate all Quality systems of the firm and will also have to carry out training programs. He should have a BS degree in Chemistry, Biological science, engineering with 5 -7 years of experience in quality assurance.
• Corporate Paralega –id: 562: In this, the individual will be responsible for providing contract administration management and has to assist the legal department personnel with several administrative functioning. He could be a graduate in any field with at least 5 years of paralegal experience.
• Accounts Payable representative – id: 563: In this, the individual is responsible for performing invoice match, coding and approvals and verification of payment authorization. The candidate should be ADP expense expert and should have knowledge in Microsoft Great Plains.

Bio-Learn: Bridge to Your Career!

Liatris Biosciences LLP is an emerging Bioinformatics company in Cochin (Kerala), offering Bio-IT services to Pharma, Biotech & Chemical industries worldwide. Bio-Learn - A subsidiary of Liatris Bio has been started to act as a bridge between academia and industry. At Bio-Learn, we provide industrial training programs, live projects to Biotechnology students and working professionals. Candidates will be trained and guided by well experienced industry experts from Pharma, Biotech and IT domains.

Training / Project Areas:
Bioinformatics, Cheminformatics & Computational Chemistry, Computer Aided Drug Design (CADD), Perl & Bio-Perl for Biologists

Location:
Liatris Bio, Cochin, Kerala OR in-house training (on-demand)

Eligibility:
Graduate, post-graduate, doctorial scholars & students in science, pharmacy, & medicine

For Registration and Details Contact:
LIATRIS BIOSCIENCES LLP
X/95-G, K C Towers, 3rd Floor, Near CSEZ
Kakkanad Cochin, Kerala - 682037
Email: training@liatrisbio.com
Ph: 0484 4016 432, 944 700 6084

Follow us: https://www.facebook.com/liatrisbio

Regards,
Team Liatris Bio

Latest Images